MCID: ENT004
MIFTS: 51

Enthesopathy

Categories: Bone diseases, Muscle diseases

Aliases & Classifications for Enthesopathy

MalaCards integrated aliases for Enthesopathy:

Name: Enthesopathy 12 44 15 17 71
Rheumatism 71

Classifications:



External Ids:

Disease Ontology 12 DOID:204
ICD9CM 34 726.90
MeSH 44 D000070676
SNOMED-CT 67 278525009
ICD10 32 M77.9 M79.0
UMLS 71 C0035435 C0242490

Summaries for Enthesopathy

Disease Ontology : 12 A connective tissue disease characterized by damage of tissues located in the entheses, the site of insertion of tendons or ligaments into bones or joint capsules, with symptoms of pain, swelling and inflammation.

MalaCards based summary : Enthesopathy, also known as rheumatism, is related to pustulosis of palm and sole and spondylitis, and has symptoms including myalgia, joint symptom and musculoskeletal symptom. An important gene associated with Enthesopathy is PHEX (Phosphate Regulating Endopeptidase Homolog X-Linked), and among its related pathways/superpathways are Parathyroid hormone synthesis, secretion and action and Endochondral Ossification. The drugs Ixekizumab and Colchicine have been mentioned in the context of this disorder. Affiliated tissues include entheses, skin and cortex, and related phenotypes are cardiovascular system and homeostasis/metabolism

Wikipedia : 74 An enthesopathy refers to a disorder involving the attachment of a tendon or ligament to a bone. This... more...

Related Diseases for Enthesopathy

Diseases related to Enthesopathy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 319)
# Related Disease Score Top Affiliating Genes
1 pustulosis of palm and sole 31.0 TNF CRP CCR6
2 spondylitis 30.8 TNF ERAP1 CRP CCR6
3 reactive arthritis 30.5 TNF CRP CCR6
4 brucellosis 30.4 TNF MEFV CRP
5 bursitis 30.4 TNF LAPTM4A CRP
6 familial mediterranean fever 30.4 TNF MEFV CRP
7 plantar fasciitis 30.3 LAPTM4A CRP
8 epicondylitis 30.3 LAPTM4A ACAN
9 osteomyelitis 30.2 TNF MEFV CRP
10 hyperostosis 30.2 KL GALNT3 FGF23 ANKH
11 arthropathy 30.2 TNF CRP ANKH ACAN
12 synovitis 30.1 TNF CRP ACAN
13 juvenile ankylosing spondylitis 30.1 TNF MEFV ERAP1
14 periarthritis 30.0 MEFV ENPP1 ANKH
15 hypophosphatemic rickets, x-linked recessive 30.0 SLC34A3 PHEX MEPE FGF23 ENPP1
16 ankylosis 30.0 TNF ENPP1 CCR6 ANKH
17 tenosynovitis 30.0 TNF CRP
18 chronic recurrent multifocal osteomyelitis 30.0 TNF MEFV CRP
19 dysentery 30.0 TNF CRP CCR6
20 temporal arteritis 29.9 TNF CRP CCR6
21 bone inflammation disease 29.7 TNF CRP CCR6 ACAN
22 spondyloarthropathy 1 29.7 TNF PTH ERAP1 CRP CCR6 ANKH
23 chondromalacia 29.7 TNF CRP ACAN
24 iritis 29.7 TNF ERAP1 CRP CCR6
25 celiac disease 1 29.3 TNF PTH CRP CCR6
26 osteomalacia 29.2 SLC34A3 PTH PHEX MEPE FGF23 ENPP1
27 rickets 29.1 SLC34A3 PTH PHEX MEPE KL FGF23
28 hypophosphatemia 29.1 SLC34A3 PTH PHEX MEPE KL FGF23
29 arthritis 28.7 TNF PTH MEFV CRP CCR6 ANKH
30 arterial calcification of infancy 28.6 SLC34A3 PHEX KL GALNT3 FGF23 ENPP1
31 hypophosphatemic rickets, x-linked dominant 28.5 SLC34A3 PTH PHEX MEPE KL GALNT3
32 autosomal recessive hypophosphatemic rickets 28.1 SLC34A3 PTH PHEX MEPE KL GALNT3
33 bone disease 27.9 TNF SLC34A3 PTH PHEX FGF23 CCR6
34 diffuse idiopathic skeletal hyperostosis 11.0
35 hereditary hypophosphatemic rickets 10.9
36 inflammatory spondylopathy 10.5
37 psoriatic arthritis 10.4
38 spondyloarthropathy 10.4
39 psoriasis 10.4
40 opsismodysplasia 10.4 PHEX FGF23
41 ankylosing spondylitis 1 10.4 FGF23 CRP
42 tendinitis 10.4
43 enterocolitis 10.4 TNF CRP
44 amyloidosis aa 10.4 MEFV CRP
45 suppurative lymphadenitis 10.4 CRP CCR6
46 drug reaction with eosinophilia and systemic symptoms 10.4 TNF CRP
47 suppurative periapical periodontitis 10.3 PHEX CRP
48 hereditary periodic fever syndrome 10.3 TNF MEFV
49 anterior scleritis 10.3 TNF CRP
50 rheumatoid arthritis interstitial lung disease 10.3 TNF CRP

Comorbidity relations with Enthesopathy via Phenotypic Disease Network (PDN):


Acute Cystitis Hypertension, Essential

Graphical network of the top 20 diseases related to Enthesopathy:



Diseases related to Enthesopathy

Symptoms & Phenotypes for Enthesopathy

UMLS symptoms related to Enthesopathy:


myalgia, joint symptom, musculoskeletal symptom

MGI Mouse Phenotypes related to Enthesopathy:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.17 ANKH CRP ENPP1 ERAP1 FGF23 GALNT3
2 homeostasis/metabolism MP:0005376 10.17 ANKH CCR6 CRP EMP1 ENPP1 FGF23
3 hematopoietic system MP:0005397 10.11 ANKH CCR6 ERAP1 FGF23 GALNT3 KL
4 immune system MP:0005387 10.07 ANKH CCR6 CRP ENPP1 ERAP1 FGF23
5 craniofacial MP:0005382 9.95 ANKH ENPP1 GALNT3 KL PHEX PTH
6 limbs/digits/tail MP:0005371 9.81 ANKH ENPP1 FGF23 GALNT3 KL LAPTM4A
7 renal/urinary system MP:0005367 9.5 ENPP1 ERAP1 FGF23 GALNT3 KL PHEX
8 skeleton MP:0005390 9.44 ANKH ENPP1 ERAP1 FGF23 GALNT3 KL

Drugs & Therapeutics for Enthesopathy

Drugs for Enthesopathy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 252)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 Ixekizumab Approved, Investigational Phase 4 1143503-69-8
2
Colchicine Approved Phase 4 64-86-8 6167 2833
3
Febuxostat Approved Phase 4 144060-53-7 134018
4
Hydrocortisone acetate Approved, Vet_approved Phase 4 50-03-3
5
Hydrocortisone Approved, Vet_approved Phase 4 50-23-7 5754
6
Etanercept Approved, Investigational Phase 4 185243-69-0
7
Hydroxychloroquine Approved Phase 4 118-42-3 3652
8
Tofacitinib Approved, Investigational Phase 4 477600-75-2
9
Ravulizumab Approved, Investigational Phase 4 1803171-55-2
10
Protein C Approved Phase 4
11
Abatacept Approved Phase 4 332348-12-6 10237
12
Methotrexate Approved Phase 4 1959-05-2, 59-05-2 126941
13
Levoleucovorin Approved, Investigational Phase 4 68538-85-2 149436
14
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
15
Heparin Approved, Investigational Phase 4 9005-49-6 772 9812414
16
Acetaminophen Approved Phase 4 103-90-2 1983
17
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
18
Folic acid Approved, Nutraceutical, Vet_approved Phase 4 59-30-3 6037
19
Uric acid Investigational Phase 4 69-93-2 1175
20 Antimitotic Agents Phase 4
21 Tubulin Modulators Phase 4
22 Diacetylrhein Phase 4
23 Hematinics Phase 4
24 Hydrocortisone 17-butyrate 21-propionate Phase 4
25 Hydrocortisone hemisuccinate Phase 4
26 Antibodies, Monoclonal Phase 4
27 Gastrointestinal Agents Phase 4
28 Anti-Infective Agents Phase 4
29 Antiparasitic Agents Phase 4
30 Antiprotozoal Agents Phase 4
31 Antimalarials Phase 4
32 Anti-Bacterial Agents Phase 4
33 Complement System Proteins Phase 4
34 Angiogenesis Inhibitors Phase 4
35 Heptavalent Pneumococcal Conjugate Vaccine Phase 4
36 Pharmaceutical Solutions Phase 4
37 Vaccines Phase 4
38 Immunosuppressive Agents Phase 4
39 Immunologic Factors Phase 4
40 Vitamin B Complex Phase 4
41 Folic Acid Antagonists Phase 4
42 Antimetabolites Phase 4
43 Antirheumatic Agents Phase 4
44 Folate Phase 4
45 Dermatologic Agents Phase 4
46 Vitamin B9 Phase 4
47 Anti-Inflammatory Agents Phase 4
48 Anti-Inflammatory Agents, Non-Steroidal Phase 4
49 Analgesics, Non-Narcotic Phase 4
50 Analgesics Phase 4

Interventional clinical trials:

(show top 50) (show all 289)
# Name Status NCT ID Phase Drugs
1 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
2 A Multicentre, Double-Blind, Placebo-Controlled, Randomized Study of Etanercept in the Treatment of Adults Patients With Refractory Heel Enthesitis in Spondylarthropathy Completed NCT00420303 Phase 4 Etanercept
3 Diacerein Combined With Febuxostat Relieves Symptoms of Gout by Suppressing IL-1βinflammation Completed NCT02060552 Phase 4 Diacerein;Colchicine;Febuxostat
4 Comparison of Combination Disease Modifying Antirheumatic Drugs (DMARDs) With Single Drug (Methotrexate) Therapy in Early Rheumatoid Arthritis Completed NCT02644499 Phase 4 Methotrexate;Leflunomide;Hydroxychloroquine;Prednisolone;Folic Acid
5 Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Three Years' Following-up Study Completed NCT02915354 Phase 4 Etanercept
6 Patient Self-administration of Cortisol for Cortisol-responding Disorders in Men and Women Over the Age of 17, Demonstration of Double-blind Trial Results Completed NCT03558971 Phase 4 Cortisol
7 A 52-Week Multicenter, Randomized, Open-Label, Parallel- Group Study Evaluating the Efficacy and Safety of Ixekizumab Versus Adalimumab in Patients With Psoriatic Arthritis Who Are Biologic Disease-Modifying Anti-Rheumatic Drug Naive Completed NCT03151551 Phase 4 Ixekizumab;Adalimumab
8 Effects of Different Anti-rheumatic Treatments of Arthritis on Antibody Response Following Pneumococcal Vaccination Using Prevenar® Completed NCT00828997 Phase 4
9 Sequential Application of Yisaipu® and Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Treating Mild-to-Moderate Ankylosing Spondylitis: the Mid-term Follow-up Result Completed NCT03411798 Phase 4 Yisaipu®
10 mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) Recruiting NCT04390464 Phase 4 Ravulizumab;Baricitinib
11 Capability of Tofacitinib or Etanercept to Accelerate Clinical Relevant Tapering of Non-steroidal Anti-inflammatory Drugs (NSAID) and Treat-to-target Guided De-escalation of Corticosteroids in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Previous csDMARD Therapy (AcceleRAte) Recruiting NCT04485325 Phase 4 Tofacitinib
12 Relevance of Monitoring Blood Levels Compared to Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases: Adherence and Understanding the Possible Underlying Mechanisms Involved in Effectiveness and in Adverse Effects Recruiting NCT03122431 Phase 4 Thalidomide;Hydroxychloroquine reduced;Hydroxychloroquine high
13 Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease. Impact of Antirheumatic Treatment on Antibody Response. Active, not recruiting NCT03762824 Phase 4
14 EFFECTS OF ABATACEPT ON THE PROGRESSION TO RHEUMATOID ARTHRITIS IN PATIENTS WITH PALINDROMIC RHEUMATISM (PALABA) Not yet recruiting NCT03669367 Phase 4 Abatacept Injection;hydroxycloroquina
15 Safety and Immunogenicity of a Recombinant Subunit Herpes Zoster Vaccine in Patients With Rheumatic Diseases Undergoing Immunosuppressive or Biologic/Targeted DMARD Therapies: a Double-blind Randomized Placebo-controlled Trial Not yet recruiting NCT04748939 Phase 4
16 Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure Terminated NCT01823393 Phase 4 Heparin;NaCl
17 A Study to Evaluate the Clinical Benefits of Tramadol/Acetaminophen (Ultracet®) vs. Diclofenac (Voltaren®) in the Treatment of Pain in Patients With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs) Terminated NCT00766402 Phase 4 Tramadol /acetaminophen;Diclofenac
18 Randomized, Phase IV, Placebo-controlled, Comparative Study to Evaluate the Efficacy and Safety of Tapering Methotrexate (MTX) Dosage Versus Maintaining the Dosage in Patients With Severe Active Rheumatoid Arthritis (RA) Who Have Demonstrated an Inadequate Response (IR) to Prior Disease-modifying Anti-rheumatic Drugs (DMARDs) Treatment and Have Initiated RoActemra (RoActemra, TCZ) in Combination With MTX Terminated NCT01661140 Phase 4 Methotrexate (stable dose);Tocilizumab;Methotrexate (tapering dose)
19 Treatment for Achilles Tendinopathy Unknown status NCT00835939 Phase 2, Phase 3 25% Dextrose and 1% Lidocaine;Lidocaine
20 Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir of Chinese HIV/AIDS Patients In Acute HIV-1 Infection Unknown status NCT02219672 Phase 3 Triplitode;Tenofovir plus lamivudine plus Lopinavir / ritonavir plus raltegravir
21 Efficiency of Radiofrequency Ablation for Surgical Treatment of Chronic Atrial Fibrillation With Rheumatic Valve Disease Unknown status NCT01013688 Phase 3
22 Phase III Study Comparing Association of Anti-inflammatory and Anti-rheumatic Unknown status NCT02448199 Phase 3 Meloxicam and Glucosamine;Meloxicam;Glucosamine
23 Multicenter Comparative Randomised Double-blind Placebo-controlled Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line of Biological Therapy of Patients With Active Rheumatoid Arthritis Completed NCT02744196 Phase 3 Placebo;Methotrexate
24 DOES ETANERCEPT INFLUENCE TWEAK MODULATION OF INFLAMMATION DURING INFLAMMATORY RHEUMATISMS (PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITIS)? Completed NCT02164214 Phase 3 etanercept Treatment
25 A Randomized, Double-blind, Placebo-controlled Multicenter Study of Subcutaneous Secukinumab to Demonstrate Efficacy in the Treatment of Enthesitis at the Achilles Tendon up to 1 Year in Adult Patients With Active Psoriatic Arthritis (PsA) and Axial Spondyloarthritis (axSpA) (ACHILLES) Completed NCT02771210 Phase 3 Secukinumab Placebo
26 A Double-blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis Completed NCT01166282 Phase 3
27 A Three-part Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Secukinumab Treatment in Juvenile Idiopathic Arthritis Subtypes of Psoriatic and Enthesitis-related Arthritis Completed NCT03031782 Phase 3 AIN457
28 Long-term Extension Study of Safety During Treatment With Tocilizumab (MRA) in Patients Completing Treatment in MRA Core Studies Completed NCT00720798 Phase 3 Tocilizumab;Disease-modifying anti-rheumatic drugs;Non-steroidal anti-inflammatory drugs;Oral corticosteroids
29 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis Completed NCT01721057 Phase 3 Placebo;Baricitinib;cDMARD
30 Comparison of Sulfasalazine Versus Leflunomide Based Combination Disease Modifying Anti-rheumatic Drug Therapy (DMARD) in Patients With Rheumatoid Arthritis Failing Methotrexate Monotherapy : A Randomized Control Trial Completed NCT02930343 Phase 3 Methotrexate;Leflunomide;Hydroxychloroquine;Prednisolone;Folic Acid;Sulfasalazine
31 Sun Yat-sen University Cancer Center Completed NCT03674294 Phase 3 Aprepitant;Palonosetron;Dexamethasone;Placebo Oral Tablet
32 A Randomized Trial of Pocket-Echocardiography Integrated Mobile Health Device Assessments in Modern Structural Heart Disease Clinics Completed NCT02881398 Phase 2, Phase 3
33 An Open Label Study of the Safety During Treatment With Tocilizumab (TCZ), in Combination With Disease Modifying Anti-rheumatic Drugs (DMARDs), in Patients With Moderate to Severe Rheumatoid Arthritis Completed NCT01214733 Phase 3 tocilizumab [RoActemra/Actemra]
34 An Open-Label, Multi-Center Study to Assess the Safety and Efficacy of the Fully Human Anti-TNF-α Monoclonal Antibody Adalimumab (D2E7) When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis Completed NCT00448383 Phase 3
35 A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of LY2127399 in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy (FLEX O) Completed NCT01202760 Phase 3 LY2127399;Placebo
36 Prevention of Glucocorticoid-Induced Osteoporosis in Patients With Rheumatic Diseases. The STOP-Study: a Randomized Placebo Controlled Trial With Alendronate Versus Alfacalcidol. Completed NCT00138983 Phase 3 Alendronate versus alfacalcidol (1-alpha OH vitamin D)
37 A Phase III, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BMS-188667 in Subjects With Active Rheumatoid Arthritis on Background Disease Modifying Anti-Rheumatic Drugs (DMARDS) Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy Completed NCT00048581 Phase 3 Abatacept;Placebo;Abatacept
38 Open-Label, Phase IIIb Study to Evaluate the Efficacy and Safety of Subcutaneous (SC) Tocilizumab Monotherapy or Combination Therapy With Methotrexate (MTX) or Other Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Patients With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-Tumour Necrosis Factor (Anti-TNF) Biologic Agent Completed NCT02046603 Phase 3 Tocilizumab;DMARDs;Oral Corticosteroids;Methotrexate
39 A Randomized, Double-blind, Parallel Group Study of Safety and the Effect on Clinical Outcome of Tocilizumab Subcutaneous (sc) Versus Placebo sc in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Moderate to Severe Active Rheumatoid Arthritis Completed NCT01232569 Phase 3 Tocilizumab 162 mg;Placebo
40 A Randomized, Double-blind, Placebo-controlled, Multicenter, Phase 3 Study to Assess the Efficacy and Safety of Filgotinib Administered for 24 Weeks in Combination With Conventional Synthetic Disease-modifying Anti-rheumatic Drug(s) (csDMARDs) to Subjects With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic DMARD(s) Treatment Completed NCT02873936 Phase 3 Filgotinib;Placebo to match filgotinib;csDMARDs
41 Assessment of the Early Efficacy Response Rate of Leflunomide According to the Initial Dosing Regimen in the Treatment of Naive-DMARD (Disease Modifying Anti-Rheumatic Drug) Early RA (Rheumatoid Arthritis)-Patients Completed NCT00596206 Phase 3 leflunomide
42 An Open-label, Prospective, Multi-Centre Study to Assess the Safety and Efficacy of Adalimumab (Humira®) When Added to Inadequate Standard Anti-Rheumatic Therapy in Patients With Active Rheumatoid Arthritis Completed NCT01231321 Phase 3 adalimumab
43 A Randomized, Double-blind, Parallel Group Study of the Safety and Effect on Clinical Outcome of Tocilizumab SC Versus Tocilizumab IV, in Combination With Traditional Disease Modifying Anti-rheumatic Drugs (DMARDs), in Patients With Moderate to Severe Active Rheumatoid Arthritis Completed NCT01194414 Phase 3 tocilizumab SC;tocilizumab IV;placebo to tocilizumab SC;placebo to tocilizumab IV;Disease-modifying antirheumatic drugs (DMARDs)
44 An Open-Label, Prospective Study of the Safety of Rituximab in Combination With Other Disease-Modifying Anti-Rheumatic Drugs in Subjects With Active Rheumatoid Arthritis Completed NCT00443651 Phase 3 Rituximab;Anti-inflammatory drugs
45 A Randomized, Double-blind Trial of the Safety of Anti-TNF Chimeric Monoclonal Antibody (Infliximab) in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Rheumatoid Arthritis on Standard Disease-modifying Anti-Rheumatic Drug Background Therapy. Completed NCT00036387 Phase 3 Infliximab
46 Multicenter Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy Completed NCT00646178 Phase 3 adalimumab;placebo for adalimumab
47 Randomized Placebo-controlled Study of Two Treatment Strategies Based on Tocilizumab (TCZ) With or Without Methotrexate (MTX) and Possible Addition of Other Disease-modifying Anti-rheumatic Drugs (DMARDs) in Patients... Completed NCT00810199 Phase 3 tocilizumab [RoActemra/Actemra];methotrexate;placebo
48 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) Completed NCT02955212 Phase 3 Upadacitinib;Placebo
49 An Extension Study of Subcutaneous Secukinumab to Evaluate the Long-term Efficacy, Safety and Tolerability up to 4 Years in Patients With Juvenile Idiopathic Arthritis Subtypes of Juvenile Psoriatic Arthritis and Enthesitis Related Arthritis Recruiting NCT03769168 Phase 3 AIN457
50 Randomized Controlled Trial of Hydroxychloroquine Versus Placebo for the Treatment of Adult Patients With Acute Coronavirus Disease 2019 - COVID-19 Recruiting NCT04342221 Phase 3 Hydroxychloroquine Sulfate;Placebo

Search NIH Clinical Center for Enthesopathy

Inferred drug relations via UMLS 71 / NDF-RT 51 :


Angelica sinensis preparation
Antirheumatic Agent [EPC]
Cyclophosphamide
Hydrocortisone
hydrocortisone acetate
HYDROCORTISONE ACETATE PWDR
HYDROCORTISONE ACETONIDE
Hydrocortisone butyrate
hydrocortisone cypionate
hydrocortisone probutate
HYDROCORTISONE PWDR
Hydrocortisone sodium phosphate
Hydrocortisone sodium succinate
hydrocortisone valerate
HYDROCORTISONE,NONSTERILE PWDR
Hydroxychloroquine
Hydroxychloroquine Sulfate
leflunomide
Penicillamine
prednisolone
prednisolone acetate
PREDNISOLONE ACETATE PWDR
PREDNISOLONE PWDR
Prednisolone sodium phosphate
prednisolone tebutate
Prednisone
PREDNISONE PWDR
Triamcinolone
Triamcinolone Acetonide
TRIAMCINOLONE ACETONIDE PWDR
triamcinolone diacetate
triamcinolone hexacetonide

Cochrane evidence based reviews: enthesopathy

Genetic Tests for Enthesopathy

Anatomical Context for Enthesopathy

The Foundational Model of Anatomy Ontology organs/tissues related to Enthesopathy:

19
Entheses

MalaCards organs/tissues related to Enthesopathy:

40
Skin, Cortex, Eye, Adrenal Cortex, Breast, Kidney, Salivary Gland

Publications for Enthesopathy

Articles related to Enthesopathy:

(showing 12255, show less)
# Title Authors PMID Year
1
Sesquiterpene lactones from Lychnophora species: Antinociceptive, anti-inflammatory, and antioxidant pathways to treat acute gout. 61
33359866 2021
2
The anti-inflammatory and analgesic activities of the ethyl acetate extract of Viburnum taitoense Hayata. 61
33359186 2021
3
Cassia sieberiana DC. leaves modulate LPS-induced inflammatory response in THP-1 cells and inhibit eicosanoid-metabolizing enzymes. 61
33359184 2021
4
Leaves of Cleome amblyocarpa Barr. And Murb. And Cleome arabica L.: Assessment of nutritional composition and chemical profile (LC-ESI-MS/MS), anti-inflammatory and analgesic effects of their extracts. 61
33359854 2021
5
Isolation and characterization of anti-inflammatory and analgesic compounds from Uapaca staudtii Pax (Phyllanthaceae) stem bark. 61
33359855 2021
6
Uses, chemical compositions, pharmacological activities and toxicology of Clematidis Radix et Rhizome- a Review. 61
33476714 2021
7
Thirty days oral Aframomum melegueta extract elicited analgesic effect but influenced cytochrome p4501BI, cardiac troponin T, testicular alfa-fetoprotein and other biomarkers in rats. 61
33096199 2021
8
22β-hydroxytingenone induces apoptosis and suppresses invasiveness of melanoma cells by inhibiting MMP-9 activity and MAPK signaling. 61
33232779 2021
9
Ethyl acetate extract of Tibetan medicine Rhamnella gilgitica ameliorated type II collagen-induced arthritis in rats via regulating JAK-STAT signaling pathway. 61
33223115 2021
10
New lupus criteria: a critical view. 61
33332888 2021
11
Polysaccaride-rich extract of Caesalpina ferrea stem barks attenuates mice acute inflammation induced by zymosan: Oxidative stress modulation. 61
33122121 2021
12
Anti-inflammatory evaluation of Scurrula ferruginea (jack) danser parasitizing on Tecoma stans (L.) H.B.K. in LPS/IFN-γ-induced RAW 264.7 macrophages. 61
33271242 2021
13
Phytochemical and biological activities of Pinus halepensis mill., and their ethnomedicinal use. 61
33276057 2021
14
Successful use of tofacitinib in the treatment of diffuse systemic sclerosis and axial spondyloarthritis: a case-based review. 61
33433730 2021
15
Friedelin exhibits antidiabetic effect in diabetic rats via modulation of glucose metabolism in liver and muscle. 61
33271243 2021
16
Kirenol, darutoside and hesperidin contribute to the anti-inflammatory and analgesic activities of Siegesbeckia pubescens makino by inhibiting COX-2 expression and inflammatory cell infiltration. 61
33152433 2021
17
Association of Genetic Polymorphisms in DC-SIGN, Toll-Like Receptor 3, and Tumor Necrosis Factor α Genes and the Lewis-Negative Phenotype With Chikungunya Infection and Disease in Nicaragua. 61
33535235 2021
18
Phytochemical Investigation and Biological Activities of Lantana rhodesiensis. 61
33562771 2021
19
Iliotibial band enthesopathy: an unusual cause of lateral knee pain post total knee replacement. 61
33591565 2021
20
Genetic identification of medicinally used Salacia species by nrDNA ITS sequences and a PCR-RFLP assay for authentication of Salacia-related health foods. 61
33588011 2021
21
Tophaceous gout of the atlantoaxial joint: a case report. 61
33588945 2021
22
Screening the elite chemotypes of Gloriosa superba L. in India for the production of anticancer colchicine: simultaneous microwave-assisted extraction and HPTLC studies. 61
33546591 2021
23
Neuropathic Pain in the Eyes, Body, and Mouth: Insights from the Sjögren's International Collaborative Clinical Alliance. 61
33527744 2021
24
[Threat of a SARS-CoV-2 endemic in a large hospital specialized in rheumatic diseases-relative all clear through consistent testing]. 61
33495854 2021
25
[Occurrence of spinal disorders and associated factors among the elderly: a population study in a municipality in the deep south of Brazil]. 61
33605348 2021
26
Phytochemicals and biological properties of Annona coriacea Mart. (Annonaceae): A systematic review from 1971 to 2020. 61
33484716 2021
27
Standardization of Kaempferia galanga L. rhizome and vasorelaxation effect of its key metabolite ethyl p-methoxycinnamate. 61
33571614 2021
28
Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider. 61
33589438 2021
29
Raynaud Phenomenon in Systemic Sclerosis: Does Digital Thermal Monitoring Correlate to Specific Nailfold Videocapillaroscopy Abnormalities? 61
32541075 2021
30
A comprehensive quality evaluation of Fuzi and its processed product through integration of UPLC-QTOF/MS combined MS/MS-based mass spectral molecular networking with multivariate statistical analysis and HPLC-MS/MS. 61
33039630 2021
31
Health and Subjective Views on Aging: Longitudinal Findings from the ActiFE Ulm Study. 61
33528511 2021
32
Performance of the 2019 EULAR/ACR systemic lupus erythematosus classification criteria in a cohort of patients with biopsy-confirmed lupus nephritis. 61
33558437 2021
33
'Black and white and every wrong colour': The medical history of Jane Austen and the possibility of systemic lupus erythematosus. 61
33596714 2021
34
Performance of 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a pediatric population - a multicenter study. 61
33560345 2021
35
Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation. 61
33555998 2021
36
Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome. 61
33567548 2021
37
Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review. 61
33543338 2021
38
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance. 61
33568386 2021
39
RA-XII, a bicyclic hexapeptidic glucoside isolated from Rubia yunnanensis Diels, exerts antitumor activity by inhibiting protective autophagy and activating Akt-mTOR pathway in colorectal cancer cells. 61
33017635 2021
40
Fibromyalgia in patients with psoriatic arthritis: Relationship with enthesopathy, sleep, fatigue and quality of life. 61
32951342 2021
41
Using internet search data to explore the global public concerns in ankylosing spondylitis. 61
32094142 2021
42
Comorbidity between depressive symptoms and chronic conditions - findings from the Indonesia Family Life Survey. 61
33220559 2021
43
Good response to methotrexate is associated with a decrease in the gene expression of ABCG2, a drug transporter, in patients with rheumatoid arthritis. 61
33492182 2021
44
Anti-rheumatoid arthritis effects of iridoid glucosides from Lamiophlomis rotata (Benth.) kudo on adjuvant-induced arthritis in rats by OPG/RANKL/NF-κB signaling pathways. 61
32980481 2021
45
Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical phenotypes in a Spanish multicentre registry (REERIGG4). 61
32658963 2021
46
EULAR recommendations for the reporting of ultrasound studies in rheumatic and musculoskeletal diseases (RMDs). 61
33483318 2021
47
2019 EULAR points to consider for the assessment of competences in rheumatology specialty training. 61
32788400 2021
48
Cissampelos pareira L.: A review of its traditional uses, phytochemistry, and pharmacology. 61
33485976 2021
49
Pharmacological insights into Merremia vitifolia (Burm.f.) Hallier f. leaf for its antioxidant, thrombolytic, anti-arthritic and anti-nociceptive potential. 61
33324970 2021
50
Solitary 68Ga-PSMA-Avid Proximal Tibial Prostatic Adenocarcinoma Metastasis Mimicking Enthesopathy. 61
33156056 2021
51
Genus Gentiana: A review on phytochemistry, pharmacology and molecular mechanism. 61
32931880 2021
52
Aberrant distribution of CD3+CD56+ NKT-like cells in patients with primary Sjögren's syndrome. 61
32242817 2021
53
Angiotensin-(1-7) attenuates collagen-induced arthritis via inhibiting oxidative stress in rats. 61
33398523 2021
54
Ethnomedicinal uses, phytochemistry, and biological activities of plants of the genus Gynura. 61
33465439 2021
55
Pharmacological and toxicological effects of Ruta chalepensis L. on experimentally induced seizures and electroencephalographic spectral power in mice. 61
33485978 2021
56
2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older. 61
32332077 2021
57
Establishing research priorities related to osteoarthritis care via stakeholder input from patients. 61
33543702 2021
58
EULAR recommendations for a core data set for pregnancy registries in rheumatology. 61
33055080 2021
59
New EULAR/ACR 2019 SLE Classification Criteria: defining ominosity in SLE. 61
33452003 2021
60
Value of multilevel sectioning of labial salivary gland biopsies in the diagnosis of Sjögren's syndrome. 61
33189649 2021
61
Antioxidant, anti-inflammatory, antibacterial, and analgesic activities and mechanisms of quinolines, indoles and related derivatives. 61
33430728 2021
62
Cereus hildmannianus (K.) Schum. (Cactaceae): Ethnomedical uses, phytochemistry and biological activities. 61
32898627 2021
63
Improvement from ixekizumab treatment in patients with psoriatic arthritis who have had an inadequate response to one or two TNF inhibitors. 61
33479721 2021
64
Disease activity at the entheses and joints are correlated in psoriatic arthritis when explored with ultrasound. 61
33427623 2021
65
Abdominal symptoms during Sjogren's syndrome: a pilot study. 61
33468262 2021
66
Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the Juvenile Inflammatory Rheumatism cohort. 61
33439385 2021
67
The Challenge of Very Early Systemic Sclerosis: A Combination of Mild and Early Disease? 61
32173655 2021
68
Association between core stability and physical function, functional performance in patients with systemic sclerosis. 61
33463900 2021
69
Gastrointestinal Henoch-Schönlein purpura successfully treated with Mycophenolate Mofetil: Description of 2 case reports. 61
33429774 2021
70
Incidence and risk of developing rheumatic diseases in 19,724 patients with palindromic rheumatism in South Korea: A nationwide population-based study. 61
33359768 2021
71
Update οn the diagnosis and management of systemic lupus erythematosus. 61
33051219 2021
72
[Systemic lupus erythematosus]. 61
33512549 2021
73
Predictive models of infection in patients with systemic lupus erythematosus: A systematic literature review. 61
33407048 2021
74
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors. 61
32327425 2021
75
Is Palindromic Rheumatism a Pre-rheumatoid Arthritis Condition? Low Incidence of Rheumatoid Arthritis in Palindromic Rheumatism Patients Treated with Tight Control Strategy. 61
30987884 2021
76
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. 61
33485455 2021
77
Major reduction of ultrasound-detected synovitis during subcutaneous tocilizumab treatment: results from a multicentre 24 week study of patients with rheumatoid arthritis. 61
33464147 2021
78
Recommendations of the Mexican College of Rheumatology for the Management of Spondyloarthritis. 61
31285162 2021
79
A comprehensive review on traditional uses, chemical compositions, pharmacology properties and toxicology of Tetrastigma hemsleyanum. 61
32800929 2021
80
Confirmation of ethnopharmacological anti-inflammatory properties of Ocotea odorifera and determination of its main active compounds. 61
32918995 2021
81
Significance of anti-Ro/SSA antibodies in the response and retention of abatacept in patients with rheumatoid arthritis: a multicentre cohort study. 61
32880228 2021
82
Dehydroepiandrostenedione sulphate (DHEAS) levels predict high risk of rheumatoid arthritis (RA) in subclinical hypothyroidism. 61
33592022 2021
83
EULAR definition of difficult-to-treat rheumatoid arthritis. 61
33004335 2021
84
Anti-tumour necrosis factor-alpha response associated with combined CD226 and HLA-DRB1*0404 haplotype in rheumatoid arthritis. 61
33427622 2021
85
How should we treat palindromic rheumatism? A systematic literature review. 61
33401055 2020
86
Clinical Significance of Anti-Modified Citrullinated Vimentin Antibodies in Palindromic Rheumatism. 61
33283235 2020
87
Upper-Limb Entheses in Healthy Children: A Comprehensive Study by Ultrasound. 61
33264248 2020
88
[IgG4-related disease: Diagnostic criteria evolution toward the 2019 ACR/EULAR classification criteria]. 61
32732082 2020
89
Treatment of femoroacetabular impingement by arthroscopy versus anterior mini-open approach: Case-control study of a continuous series of 91 cases at a mean 4.6 years' follow-up. 61
33189663 2020
90
Long-Term Results of Pisiformectomy in a Cohort of 57 Patients. 61
33282530 2020
91
[Investigation of sleep disturbance and related factors in patients with primary Sjögren's syndrome]. 61
33331314 2020
92
Bioassay-guided isolation of anti-inflammatory diterpenoids with highly oxygenated substituents from kidney tea (Clerodendranthus spicatus). 61
33103258 2020
93
Piper sarmentosum Roxb.: A review on its botany, traditional uses, phytochemistry, and pharmacological activities. 61
32620264 2020
94
[Register and cohort studies : Overview of the most important data sources at the German Rheumatism Research Center]. 61
33258976 2020
95
[Perspectives for rheumatological health services research at the German Rheumatism Research Center]. 61
33258978 2020
96
Prevalence of musculoskeletal conditions and related disabilities in Bangladeshi adults: a cross-sectional national survey. 61
33323124 2020
97
The Risk of Presarcopenia Is Increased Among Female Patients With Primary Sjögren's Syndrome. 61
33337813 2020
98
The Cholinesterase Inhibitory Properties of Stephaniae Tetrandrae Radix. 61
33327436 2020
99
Epidemiology of chronic back pain among adults and elderly from Southern Brazil: a cross-sectional study. 61
33419714 2020
100
[Regional cooperative rheumatology centers : Networking of rheumatology in Germany for over 25 years]. 61
33258974 2020
101
[Translational healthcare research : Show what is-Angela Zink, the grande dame of public health research in rheumatology]. 61
33258975 2020
102
The complete chloroplast genome data of Areca catechu (Arecaceae). 61
33195770 2020
103
Compliance of Familial Mediterranean Fever Patients With Regular Follow-up Visits and Associated Factors. 61
33298810 2020
104
[Infliximab in infantile Takayasu arteritis: a case report and literature review]. 61
33256323 2020
105
Serum MicroRNA Signature as a Diagnostic and Therapeutic Marker in Patients with Psoriatic Arthritis. 61
32115427 2020
106
Ultra-high frequency ultrasound (UHFUS) applications in Sjogren syndrome: narrative review and current concepts. 61
33447577 2020
107
Safety and Effectiveness of Biologic Disease-Modifying Antirheumatic Drugs in Older Patients with Rheumatoid Arthritis: A Prospective Cohort Study. 61
33205322 2020
108
Low-Level Proteinuria in Systemic Lupus Erythematosus. 61
33305127 2020
109
Systemic lupus erythematosus 2020. 61
32586673 2020
110
A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum. 61
33028176 2020
111
Triterpenoids and steroids isolated from Anatolian Capparis ovata and their activity on the expression of inflammatory cytokines. 61
32915696 2020
112
[Progress in interferon: A treatment of Behcet syndrome]. 61
33331331 2020
113
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19. 61
32910933 2020
114
Ankylosing Spondylitis With Bilateral Symmetrical Uptake in the Greater Trochanters on Bone Scan. 61
32947421 2020
115
Periodontal diseases and its association with disease activity in ankylosing spondylitis/SpA: A systematic review. 61
33284102 2020
116
Er Miao San, a traditional Chinese herbal formula, attenuates complete Freund's adjuvant-induced arthritis in rats by regulating Th17/Treg cells. 61
32037930 2020
117
CD34+ CD133+ CD309+ circulating angiogenic cell level is reduced but positively related to hydroxychloroquine use in SLE patients - a case-control study and meta-regression analysis. 61
33369679 2020
118
Therapeutic Potential of Lindera obtusiloba: Focus on Antioxidative and Pharmacological Properties. 61
33322185 2020
119
The Genus Schefflera: a review of traditional uses, phytochemistry and pharmacology. 61
33301919 2020
120
Association of MICA-129Met/Val polymorphism with clinical outcome of anti-TNF therapy and MICA serum levels in patients with rheumatoid arthritis. 61
32123296 2020
121
Circulating Small Noncoding RNA Biomarkers of Response to Triple Disease-modifying Antirheumatic Drug Therapy in White Women With Early Rheumatoid Arthritis. 61
32541082 2020
122
The Story Behind the Use of Glucocorticoids in the Treatment of Rheumatoid Arthritis. 61
33360225 2020
123
Association of Dysregulated Central Pain Processing and Response to Disease-Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis. 61
32683800 2020
124
Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study. 61
33119861 2020
125
Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020. 61
32963049 2020
126
Curious Case of a Retroperitoneal Mass With an Elevated Serum IgG3 Level-An Exception to the 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease: Comment on the Article by Wallace et al. 61
32564475 2020
127
Correspondence on 'The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease'. 61
33148699 2020
128
A novel herbal formulation consisting of red ginseng extract and Epimedium koreanum Nakai-attenuated dextran sulfate sodium-induced colitis in mice. 61
33192127 2020
129
Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases. 61
32930863 2020
130
Risk factors associated with history of falls in adults with intellectual disability. 61
32911340 2020
131
Imaging of calcific tendinopathy around the shoulder: usual and unusual presentations and common pitfalls. 61
33151457 2020
132
Sclerotherapy and prolotherapy for chronic patellar tendinopathies - a promising therapy with limited available evidence, a systematic review. 61
33165667 2020
133
European League Against Rheumatism (EULAR) recommendations and EULAR/American College of Rheumatology criteria-documenting progress in lupus. 61
33140089 2020
134
Thuja occidentalis L. (Cupressaceae): Ethnobotany, Phytochemistry and Biological Activity. 61
33228192 2020
135
Lateral epicondylitis: Current concepts. 61
33123709 2020
136
Enthesopathy-An Underappreciated Role in Osteoarthritis? 61
33156036 2020
137
Corrigendum to "Three tesla and 3D multiparametric combined imaging evaluation of axial spondyloarthritis and pelvic enthesopathy" [Eur. J. Radiol. (2020) 108916]. 61
32956999 2020
138
Timing of Surgical Intervention for Dysphagia in Patients With Diffuse Idiopathic Skeletal Hyperostosis: A Systematic Review and Meta-Analysis. 61
33239502 2020
139
Platelet-Rich Plasma Therapy in the Treatment of Diseases Associated with Orthopedic Injuries. 61
32380937 2020
140
Development of New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria. 61
33253499 2020
141
Neighborhood's locality, road types, and residents' multimorbidity: evidence from China's middle-aged and older adults. 61
33198728 2020
142
First Report of Pestalotiopsis lushanensis Causing Brown Leaf Spot on Sarcandra glabra in China. 61
33231526 2020
143
Genus Alangium - A review on its traditional uses, phytochemistry and pharmacological activities. 61
33161060 2020
144
High Prevalence of Probable Sarcopenia in a Representative Sample From Colombia: Implications for Geriatrics in Latin America. 61
33197411 2020
145
Vaccinology Education of Nurses and the Current Immunoprophylaxis Recommendations for Children with Juvenile Idiopathic Arthritis. 61
33233818 2020
146
Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial. 61
33168545 2020
147
The efficacy and mechanism for action of iguratimod in primary Sjögren's syndrome patients. 61
32607949 2020
148
[The interpretation of European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies:2019 update]. 61
33120499 2020
149
Three Scrophularia Species (Scrophularia buergeriana, S. koraiensis, and S. takesimensis) Inhibit RANKL-Induced Osteoclast Differentiation in Bone Marrow-Derived Macrophages. 61
33256150 2020
150
The impact of fatigue on patients with psoriatic arthritis: a multi-center study of the TLAR-network. 61
32564159 2020
151
GlutenSpA trial: protocol for a randomised double-blind placebo-controlled trial of the impact of a gluten-free diet on quality of life in patients with axial spondyloarthritis. 61
33444189 2020
152
Validation of the 2019 European League Against Rheumatism/American College of Rheumatology Criteria Compared to the 1997 American College of Rheumatology Criteria and the 2012 Systemic Lupus International Collaborating Clinics Criteria in Pediatric Systemic Lupus Erythematosus. 61
31478595 2020
153
[How well are patients with inflammatory rheumatic diseases protected against measles?] 61
32930874 2020
154
The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic lupus erythematosus. 61
33191281 2020
155
Comparison of Three Classification Criteria Sets for Systemic Lupus Erythematosus: A Study Looking at Links to Outcome and Mortality. 61
31507091 2020
156
Performance of the 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus in Asian patients: a single-centre retrospective cohort study in Korea. 61
32083550 2020
157
New classification criteria for systemic lupus erythematosus. 61
32925250 2020
158
Co-existence of Marfan syndrome and systemic sclerosis: A case report and a hypothesis suggesting a common link. 61
32969582 2020
159
Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation. 61
32843324 2020
160
Antioxidant Activities of a New Chemotype of Piper cubeba L. Fruit Essential Oil (Methyleugenol/Eugenol): In Silico Molecular Docking and ADMET Studies. 61
33182768 2020
161
Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome. 61
32791244 2020
162
Impact of Single-Nucleotide Polymorphisms of CTLA-4, CD80 and CD86 on the Effectiveness of Abatacept in Patients with Rheumatoid Arthritis. 61
33187286 2020
163
Study on the pharmacodynamics and metabolomics of five medicinal species in Atractylodes DC. on rats with rheumatoid arthritis. 61
32890964 2020
164
The Prevalence of Sjögren's Syndrome in Rheumatoid Arthritis Patients and Their Clinical Features. 61
33230982 2020
165
EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyses of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries. 61
32873554 2020
166
Colchicine and myocardial infarction: A review. 61
32712201 2020
167
Factors associated with the poor outcomes in diabetic patients with COVID-19. 61
33072634 2020
168
The Jumper's Knee - a New Look at Non-surgical Treatment. Pilot Study. 61
33568571 2020
169
Medial humeral epicondylar lesions and discreet calcified structures in the canine elbow: radiographic description of 183 cases. 61
33081826 2020
170
History of uses, phytochemistry, pharmacological activities, quality control and toxicity of the root of Stephania tetrandra S. Moore: A review. 61
32497674 2020
171
From nutrition to medicine: Assessing hemorrhoid healing activity of Solanum melongena L. via in vivo experimental models and its major chemicals. 61
32687958 2020
172
Hypouricemia and Mortality Risk in the United States General Population. 61
33026684 2020
173
[Textual research on origin and efficacy of Tibetan medicine "Shengdeng"]. 61
33164447 2020
174
A New Diterpene and Anti-inflammatory Sesquiterpene Lactones from Sigesbeckia orientalis. 61
32957145 2020
175
[Sjögren Syndrome : the ENT specialist contributes to the workup]. 61
33026728 2020
176
Modulation of inflammatory pathways, medicinal uses and toxicities of Uvaria species: potential role in the prevention and treatment of inflammation. 61
32617790 2020
177
Relationships between Chronic Diseases and Depression among Middle-aged and Elderly People in China: A Prospective Study from CHARLS. 61
33123901 2020
178
[Periodic fever syndrome associated with mutations in the TNF type 1 receptor gene: A differential diagnosis of familial Mediterranean fever that should not be overlooked in patients of Mediterranean origin]. 61
33131906 2020
179
Comparison of Ultrasound Features of Major Salivary Glands in Sarcoidosis, Amyloidosis, and Sjögren's Syndrome. 61
31309727 2020
180
X-Linked Hypophosphatemic Rickets Manifesting as Sclerotic Bone Disease and Enthesopathy. 61
33178527 2020
181
Cardiovascular risk in psoriatic arthritis, a narrative review. 61
31958573 2020
182
Relationship between change in physical activity and in clinical status in patients with idiopathic inflammatory myopathy: A prospective cohort study. 61
32920327 2020
183
Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities. 61
32816709 2020
184
The Influence of Hand Dominance on the Degree of Deformities in Patients With Systemic Lupus Erythematosus and Jaccoud Arthropathy. 61
32332272 2020
185
Association of crossing capillaries in the finger nailfold with diabetic retinopathy in type 2 diabetes mellitus. 61
33070436 2020
186
[Clinical significance of determination of DFS70 antibodies to rule out connective tissue diseases]. 61
31889213 2020
187
Identification of Antifungal Bisphosphocholines from Medicinal Gentiana Species. 61
33052051 2020
188
A Comprehensive Review on Physiological Effects of Curcumin. 61
32746480 2020
189
A review of the traditional uses, phytochemistry, pharmacology and quality control of the ethnic medicinal plant Persicaria orientalis (L.) Spach in China. 61
33127561 2020
190
Inflammation suppression by dexamethasone via inhibition of CD147-mediated NF-κB pathway in collagen-induced arthritis rats. 61
32594339 2020
191
Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020. 61
32473418 2020
192
Factors Associated With Disease Damage in Puerto Ricans With Primary Sjögren Syndrome. 61
30870254 2020
193
Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis. 61
33001576 2020
194
[Multicenter performance of the different classification criteria for rheumatoid arthritis]. 61
33047726 2020
195
Revisiting the use of remission criteria for rheumatoid arthritis by excluding patient global assessment: an individual meta-analysis of 5792 patients. 61
33023964 2020
196
Adenosine Deaminase Gene Polymorphism and Baseline Serum Level of Adenosine Deaminase as a Biomarker of Response to Methotrexate in Rheumatoid Arthritis. 61
33044386 2020
197
French survey on the crossed needs on sexual health for chronic inflammatory rheumatism patients and healthcare professionals. 61
32621138 2020
198
Dermatomyositis induced by the secretion of Phyllomedusa bicolor or Kambô frog - A case report. 61
32473255 2020
199
African League Against Rheumatism (AFLAR) preliminary recommendations on the management of rheumatic diseases during the COVID-19 pandemic. 61
32876786 2020
200
Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus. 61
32984894 2020
201
Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2. 61
32389854 2020
202
Traditional uses, botany, phytochemistry, pharmacology, separation and analysis technologies of Euonymus alatus (Thunb.) Siebold: A comprehensive review. 61
32423879 2020
203
Tophaceous Enthesopathy Mimicking Achilles Enthesitis. 61
31107699 2020
204
[CME Sonography 93: Ultrasound of the Enthesis - Not Every "Enthesitis" Signals a Spondyloarthritis]. 61
32873169 2020
205
Distal phalangeal bone erosions observed by HR-pQCT in patients with psoriatic onycholysis. 61
32885241 2020
206
The Turkish League Against Rheumatism Recommendations for the Management of Hand Osteoarthritis Under Guidance of the Current Literature and 2018 European League Against Rheumatism Recommendations. 61
33458653 2020
207
Firm Cutaneous Nodule on the Dorsal Hand: A Case Report on Fibroblastic Rheumatism. 61
33052274 2020
208
[Participatory research in the German Rheumatism League. Content implementation and practical realisation of participatory research in a patient organisation]. 61
32753283 2020
209
Dysregulation of gut microbiome is linked to disease activity of rheumatic diseases. 61
32519049 2020
210
Patient Goals and Motivation for Thumb Carpometacarpal Osteoarthritis Surgery. 61
32988234 2020
211
De novo transcriptome sequencing of Rhododendron molle and identification of genes involved in the biosynthesis of secondary metabolites. 61
32887550 2020
212
Association between comorbidities and extraglandular manifestations in primary Sjögren's syndrome: a multicenter cross-sectional study. 61
32146615 2020
213
Validation and clinical interpretability of PsAID - psoriatic arthritis impact of disease. 61
32962756 2020
214
The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis. 61
32820672 2020
215
Utility of the EULAR Sjögren syndrome disease activity index in Japanese children: a retrospective multicenter cohort study. 61
32943063 2020
216
A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis. 61
32631205 2020
217
Frequency of Polyautoimmunity in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus. 61
32956154 2020
218
Pilea umbrosa ameliorate CCl4 induced hepatic injuries by regulating endoplasmic reticulum stress, pro-inflammatory and fibrosis genes in rat. 61
32917140 2020
219
Higher specificity of the new EULAR/ACR 2019 criteria for diagnosing systemic lupus erythematosus in patients with biopsy-proven cutaneous lupus. 61
32940207 2020
220
Evaluation of the diagnostic performance of 18F-NaF positron emission tomography/computed tomography in patients with suspected ankylosing spondylitis according to the Assessment of SpondyloArthritis International Society criteria. 61
32198119 2020
221
Decreased Bilirubin is Associated With Disease Activity of Primary Sjögren's Syndrome. 61
33458658 2020
222
The Natural Compound Notopterol Binds and Targets JAK2/3 to Ameliorate Inflammation and Arthritis. 61
32937124 2020
223
Guidelines on the Role of Nursing in Patients with Chronic Inflammatory Arthritis: Do we "AGREE II"? 61
33163862 2020
224
Systematic analysis of the metabolites of Angelicae Pubescentis Radix by UPLC-Q-TOF-MS combined with metabonomics approaches after oral administration to rats. 61
32673967 2020
225
Chemical Compounds, Pharmacological and Toxicological Activity of Brugmansia suaveolens: A Review. 61
32911850 2020
226
Anti-nociceptive and anti-inflammatory activities of ethanol extract and fractions of Morus mesozygia Stapf (Moraceae) leaves and its underlying mechanisms in rodents. 61
32387467 2020
227
Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review. 61
32535834 2020
228
Glucocorticoid receptor polymorphisms in rheumatoid arthritis: results from a single centre. 61
31820730 2020
229
Up to 5-year retention of abatacept in Belgian patients with moderate-to-severe rheumatoid arthritis: a sub-analysis of the international, observational ACTION study. 61
32556473 2020
230
Potential of neutrophil to lymphocyte ratio in predicting sustained remission in rheumatoid arthritis compared to other immune activation markers. 61
33107483 2020
231
Multiomics and Machine Learning Accurately Predict Clinical Response to Adalimumab and Etanercept Therapy in Patients With Rheumatoid Arthritis. 61
32909363 2020
232
[Disease-related knowledge acquisition through structured patient information in rheumatoid arthritis (StruPI-RA) : First results of the StruPI-RA study in Germany]. 61
32926219 2020
233
Sexual dysfunction and its determinants in women with rheumatoid arthritis. 61
32990787 2020
234
Clinical influences of anticentromere antibody on primary Sjögren's syndrome in a prospective Korean cohort. 61
32829574 2020
235
COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine. 61
32942793 2020
236
[Periprosthetic and interprothetic fractures in patients with rheumatism : Characteristics of conservative and surgical treatment]. 61
32666164 2020
237
Iguratimod treatment reduces disease activity in early primary Sjögren's syndrome: An open-label pilot study. 61
32613869 2020
238
Anti-inflammatory, analgesic activity, and toxicity of Pituranthos scoparius stem extract: An ethnopharmacological study in rat and mouse models. 61
32376367 2020
239
[Injuries in children and adolescents with inflammatory rheumatic diseases : Special risks and techniques for fracture treatment of the growing skeleton]. 61
32444884 2020
240
[Treatment of Takayasu arteritis]. 61
32430564 2020
241
Outcomes and treatment responses, including work productivity, among people with axial spondyloarthritis living in urban and rural areas: a mixed-methods study within a national register. 61
32522742 2020
242
The Performance of the New 2019-EULAR/ACR Classification Criteria for Systemic Lupus Erythematosus in Children and Young Adults. 61
32841547 2020
243
Exclusion of Cutaneous Lupus Erythematosus Subtypes From the 2019 European League Against Rheumatism/American College of Rheumatology Classifi cation Criteria for Systemic Lupus Erythematosus: Comment on the Article by Aringer et al. 61
32336046 2020
244
Gastrointestinal SLE involvement in SLE classification. Response to: ''2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus' by Aringer et al' by Cui et al. 61
32753412 2020
245
Correspondence on '2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus' by Aringer et al. 61
32753415 2020
246
Ethnomedicinal use, phytochemistry, pharmacology, and toxicology of Ajuga iva (L.,) schreb. 61
32387464 2020
247
An Unusual and Rare Case of a Seronegative Male Patient With Lupus Nephritis. 61
32821630 2020
248
Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis. 61
32503858 2020
249
A comprehensive review on ethnomedicine, phytochemistry, pharmacology, and toxicity of Tephrosia purpurea (L.) Pers. 61
32147928 2020
250
In silico investigation of phytoconstituents from Indian medicinal herb 'Tinospora cordifolia (giloy)' against SARS-CoV-2 (COVID-19) by molecular dynamics approach. 61
32762511 2020
251
Medicinal dietary plants of the Yi in Mile, Yunnan, China. 61
32859223 2020
252
Synedrella nodiflora (Linn.) Gaertn. inhibits inflammatory responses through the regulation of Syk in RAW 264.7 macrophages. 61
32765663 2020
253
Value of labial salivary gland histopathology for diagnosis of Sjögren's syndrome in patients with anti-centromere antibody positivity. 61
32691526 2020
254
Cognitive dysfunction in Sjögren's syndrome using the Montreal Cognitive Assessment Questionnaire and the Automated Neuropsychological Assessment Metrics: A cross-sectional study. 61
32608054 2020
255
American Indians Have a Higher Risk of Sjögren's Syndrome and More Disease Activity Than European Americans and African Americans. 61
31199565 2020
256
Chemical profiling of Dioscorea septemloba by High Performance Liquid Chromatography Coupled to Electrospray Ionization and Quadrupole Time-of-Flight Mass Spectrometry. 61
32676674 2020
257
Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren's Syndrome: A Randomized Clinical Trial. 61
32798283 2020
258
Treatment Strategies in Early Rheumatoid Arthritis Methotrexate Management: Results From a Prospective Cohort. 61
31112011 2020
259
The prevalence of rheumatoid arthritis in middle-aged and elderly people living in Naqu City, Tibet, Autonomous Region of China. 61
32811526 2020
260
Misperception of the Cardiovascular Risk in Patients with Rheumatoid Arthritis. 61
32824469 2020
261
Efficacy, safety and cost-effectiveness of a web-based platform delivering the results of a biomarker-based predictive model of biotherapy response for rheumatoid arthritis patients: a protocol for a randomized multicenter single-blind active controlled clinical trial (PREDIRA). 61
32867830 2020
262
Fatigue and associated factors in a multi-ethnic cohort of rheumatoid arthritis patients. 61
32597545 2020
263
Involving patients as research partners exemplified by the development and evaluation of a communication-skills training programme (KOKOS-Rheuma). 61
32676754 2020
264
Response to: 'Comment on Ye et al 'Presence of respiratory failure of COVID-19 infection in patients with rheumatism in Wuhan, China'' by Chen et al. 61
32709681 2020
265
Comment on Ye et al 'Presence of respiratory failure of COVID-19 infection in rheumatism patients in Wuhan, China'. 61
32709682 2020
266
The ethnopharmacology, phytochemistry, pharmacology and toxicology of genus Albizia: A review. 61
32278761 2020
267
Phytochemical, ethanomedicinal and pharmacological applications of escin from Aesculus hippocastanum L. towards future medicine. 61
32649293 2020
268
[Ultrasound-guided percutaneous tenotomy in chronic wrist extensor enthesopathy]. 61
32563618 2020
269
Enthesopathy, Osteoarthritis, and Mobility in X-linked Hypophosphatemia1. 61
32374835 2020
270
Lilac Tasselflower (Emilia sonchifolia) is a New Host for Peanut Witches' Broom Phytoplasma, a 16SrII-V Subgroup Strain in Taiwan. 61
32729803 2020
271
Initiating guideline-concordant gout treatment improves arterial endothelial function and reduces intercritical inflammation: a prospective observational study. 61
32653044 2020
272
Celastrol attenuates collagen-induced arthritis via inhibiting oxidative stress in rats. 61
32402948 2020
273
How do different chronic condition comorbidities affect changes in depressive symptoms of middle aged and older adults? 61
32379619 2020
274
Evaluation of soluble CD25 as a clinical and autoimmune biomarker in primary Sjögren's syndrome. 61
32940214 2020
275
Clinically significant renal involvement in primary Sjögren's syndrome is associated with important morbidity: data from the Spanish Sjögrenser cohort. 61
33095138 2020
276
Diagnostic performance of the 2012 EULAR/ACR classification criteria for polymyalgia rheumatica in Korean patients. 61
32715648 2020
277
Sonographic Evaluation of Subclinical Enthesopathy in Patients of Chronic Plaque Psoriasis. 61
32832446 2020
278
Differential microRNAs expression in calcified versus rheumatic aortic valve disease. 61
32485041 2020
279
The Impact of Dysphagia in Myositis: A Systematic Review and Meta-Analysis. 61
32650400 2020
280
COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments. 61
32472461 2020
281
Physical therapy in axial spondyloarthritis: guidelines, evidence and clinical practice. 61
32453037 2020
282
Mesenchymal stem cells and mesenchymal stem cell-derived extracellular vesicles: Potential roles in rheumatic diseases. 61
32843922 2020
283
Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD. 61
32317314 2020
284
Characterization of a subset of patients with primary Sjögren's syndrome initially presenting with C3 or C4 hypocomplementemia. 61
32809932 2020
285
Phytochemicals and biological activity of Tetracera scandens Linn. Merr. (Dilleniaceae): A short review. 61
33100780 2020
286
Biological Properties, Bioactive Constituents, and Pharmacokinetics of Some Capsicum spp. and Capsaicinoids. 61
32707790 2020
287
Investigation of the predictors of the response to Iguratimod therapy: A post-hoc analysis of post-marketing surveillance study. 61
31393189 2020
288
The complete chloroplast genome and characteristics analysis of Callistemon rigidus R.Br. 61
32515001 2020
289
Long-term hydroxychloroquine therapy improves the quality of sleep in patients with primary Sjögren's syndrome: a real-world study. 61
32692242 2020
290
Role of CT Scan in Early Diagnosis of Temporomandibular Joint Injury in Patients with Rheumatoid Arthritis. 61
33020361 2020
291
Smartphone Apps Targeting Physical Activity in People With Rheumatoid Arthritis: Systematic Quality Appraisal and Content Analysis. 61
32706727 2020
292
Predictors of fatigue and persistent fatigue in early rheumatoid arthritis: a longitudinal observational study, data from the ESPOIR cohort. 61
32351168 2020
293
The Prevalence of Rheumatoid Arthritis in Chile: A Nationwide Study Performed as Part of the National Health Survey. 61
31474598 2020
294
Evaluation of Response Criteria in Rheumatoid Arthritis Treated With Biologic Disease-Modifying Antirheumatic Drugs. 61
31058442 2020
295
Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study. 61
32704073 2020
296
Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis. 61
30098882 2020
297
Characterizing hand and wrist ultrasound pattern in primary Sjögren's syndrome: a case-control study. 61
32072351 2020
298
Genetic polymorphisms in DC-SIGN, TLR3 and TNFa genes and the Lewis-negative phenotype are associated with Chikungunya infection and disease in Nicaragua. 61
32591775 2020
299
Musculoskeletal Disorders due to Chikungunya Virus: A Real Experience in a Rheumatology Department in Neiva, Huila. 61
32576537 2020
300
[DRESS syndrome with pustules and cardiac impairment]. 61
32164921 2020
301
Prevention of Hyperuricemia by Clerodendrum trichotomum Leaf Extract in Potassium Oxonate-Induced Mice. 61
32734126 2020
302
Chondrosesamoidean ligament enthesopathy: prevalence and findings in a population of lame horses imaged with positron emission tomography. 61
32491220 2020
303
Symptomatic joint hypermobility. 61
32249022 2020
304
Thalictrum foliolosum: A lesser unexplored medicinal herb from the Himalayan region as a source of valuable benzyl isoquinoline alkaloids. 61
32135243 2020
305
[Treatment strategies in psoriatic arthritis]. 61
32492748 2020
306
Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis. 61
32381564 2020
307
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update. 61
32434812 2020
308
International league of associations for rheumatology recommendations for the management of psoriatic arthritis in resource-poor settings. 61
31950441 2020
309
[Rheumatism and art : Max Slevogt. The bon viveur and artist plagued by gout]. 61
31784820 2020
310
Performance of the new EULAR/ACR classification criteria for idiopathic inflammatory myopathies (IIM) in a large monocentric IIM cohort. 61
32024593 2020
311
A cross-sectional study of association of serostatus and extra-articular manifestations in patients with rheumatoid arthritis in a teaching hospital. 61
32984127 2020
312
Validation of the 2019 ACR/EULAR classification criteria of systemic lupus erythematosus in 100 Japanese patients: a real-world setting analysis. 61
32052228 2020
313
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. 61
32220834 2020
314
Applying the 2019 EULAR/ACR Lupus Criteria to Patients from the LUMINA Cohort. 61
32598552 2020
315
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. 61
32033937 2020
316
Nailfold Videocapillaroscopy in Systemic Sclerosis-related Pulmonary Arterial Hypertension: A Systematic Literature Review. 61
31416927 2020
317
Imaging in Vasculitis. 61
32562073 2020
318
Genome assembly of Chiococca alba uncovers key enzymes involved in the biosynthesis of unusual terpenoids. 61
32642754 2020
319
Hydrology, rheumatology, and rehabilitation: the campaigning of Fortescue Fox. 61
32568298 2020
320
Mapping analysis to predict EQ-5D-5 L utility values based on the Oxford Hip Score (OHS) and Oxford Knee Score (OKS) questionnaires in the Spanish population suffering from lower limb osteoarthritis. 61
32539838 2020
321
Ultrasound, X-ray, computed tomography and clinical tests for diagnosis of abdominal purpura in children: A retrospective study. 61
32346418 2020
322
The effect of time and temperature on shelf life of essential oil composition of Teucrium polium L. 61
32498558 2020
323
The effects of hydro-ethanolic extract of Capparis spinosa (C. spinosa) on lipopolysaccharide (LPS)-induced inflammation and cognitive impairment: Evidence from in vivo and in vitro studies. 61
32109547 2020
324
The effect of smoking on disease activity in rheumatoid arthritis - our experience. 61
33456119 2020
325
Genetic and clinical prediction models for the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a multicenter cohort study. 61
31792368 2020
326
[Association of physical activity with fatigue and functional capacity in patients with rheumatoid arthritis]. 61
32588130 2020
327
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. 61
31969328 2020
328
Serum C-Reactive Protein/Albumin Ratio in Rheumatoid Arthritis and its Relationship With Disease Activity, Physical Function, and Quality of Life. 61
32851374 2020
329
Eosinophilic granulomatous polyangiitis with IgG4 hypergammaglobulinaemia and salivary gland swelling. 61
32257216 2020
330
[Pregnancy with lupus erythematosus-an update]. 61
32236845 2020
331
Alternative causes of ankle pain in a patient with enthesopathy and X-linked hypophosphataemia. 61
32446409 2020
332
Three tesla and 3D multiparametric combined imaging evaluation of axial spondyloarthritis and pelvic enthesopathy. 61
32171917 2020
333
A Phytochemical and Ethnopharmacological Recapitulation on Hamelia patens. 61
32227313 2020
334
Evaluation of anti-inflammatory and analgesic activities of aqueous methanolic extract of Ranunculus muricatus in albino mice. 61
33191237 2020
335
The struggle with rheumatism through Dracunculus vulgaris Schott: In the light of ethnobotanical information. 61
32357826 2020
336
A comparison of the performance of the 2019 European League Against Rheumatism/American College of Rheumatology criteria and the 2012 Systemic Lupus International Collaborating Clinics criteria with the 1997 American College of Rheumatology classification criteria for systemic lupus erythematous in new-onset Chinese patients. 61
32216517 2020
337
Consensus-based evaluation of dermatoscopy versus nailfold videocapillaroscopy in Raynaud's phenomenon linking USA and Europe: a European League against Rheumatism study group on microcirculation in rheumatic diseases project. 61
32865167 2020
338
The Future of Imaging in Axial Spondyloarthritis. 61
32340703 2020
339
Antirheumatic medications in pregnancy and breastfeeding. 61
32205567 2020
340
From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention. 61
32418006 2020
341
At the crossroads of gout and psoriatic arthritis: "psout". 61
32062768 2020
342
Joint Distribution and Two-Year Outcome in 347 Patients With Monoarthritis of Less Than Sixteen Weeks' Duration. 61
28777897 2020
343
Indian Sarsaparilla (Hemidesmus indicus): Recent progress in research on ethnobotany, phytochemistry and pharmacology. 61
32007632 2020
344
Nailfold Capillaroscopy and Retinal Findings in Patients with Systemic Sclerosis: Is There An Association? 61
32695698 2020
345
Genetic heterogeneity of pediatric systemic lupus erythematosus with lymphoproliferation. 61
32443356 2020
346
Increased CD200 levels in peripheral blood mononuclear cells of patients with primary Sjögren's syndrome. 61
32180363 2020
347
[Lupus and thrombophilia : Antiphospholipid syndrome]. 61
32300863 2020
348
Inhalation of Tetrandrine-hydroxypropyl-β-cyclodextrin Inclusion Complexes for Pulmonary Fibrosis Treatment. 61
32142292 2020
349
[Treat to target in systemic lupus erythematosus]. 61
32232548 2020
350
Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register. 61
31371659 2020
351
Clinical features in primary care electronic records before diagnosis of ankylosing spondylitis: a nested case-control study. 61
32375655 2020
352
Phyllanthus acidus (L.) Skeels: A review of its traditional uses, phytochemistry, and pharmacological properties. 61
31991202 2020
353
Osthole alleviates neuropathic pain in mice by inhibiting the P2Y1-receptor-dependent JNK signaling pathway. 61
32365053 2020
354
New Criteria for Lupus. 61
32405775 2020
355
A Comparison of 2019 EULAR/ACR SLE Classification Criteria with Two Sets of Earlier SLE Classification Criteria. 61
32433832 2020
356
Foot health and quality of life in patients with rheumatoid arthritis: a cross-sectional study. 61
32423942 2020
357
Individual therapeutic DAS28-dcrit responses differentiate between effectiveness of rheumatoid arthritis therapies and reflect patient-reported outcomes: retrospective analysis of DAS28 responses in comparative tocilizumab studies. 61
32040761 2020
358
Imaging in the preclinical phases of rheumatoid arthritis. 61
31376263 2020
359
Rheumatoid Arthritis Initiating as Palindromic Rheumatism: A Distinct Clinical Phenotype? 61
31371648 2020
360
EULAR definition of "arthralgia suspicious for progression to rheumatoid arthritis" in a large cohort of patients included in a program for rapid diagnosis: role of auto-antibodies and ultrasound. 61
31933033 2020
361
A new laboratory surrogate (Monocyte Chemotactic Protein-1) for Disease Activity Score28: a favourable indicator for remission in rheumatoid arthritis. 61
32427982 2020
362
A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji). 61
32336965 2020
363
Evaluation of the Effectiveness of Orthokine Therapy: Retrospective Analysis of 1000 Cases. 61
32468996 2020
364
[Development of an indicator set for the evaluation of the population-based integrated healthcare model 'Gesundes Kinzigtal' (Healthy Kinzigtal)]. 61
32467041 2020
365
Phenobarbital rheumatism-A fresh look at an old malady: Case report and systematic review of literature. 61
32100469 2020
366
Incorporation of Salivary Gland Ultrasonography Into the American College of Rheumatology/European League Against Rheumatism Criteria for Primary Sjögren's Syndrome. 61
31254454 2020
367
Changes in the Presentation of Incident Gout and the Risk of Subsequent Flares: A Population-based Study over 20 Years. 61
31308206 2020
368
The phytochemistry, pharmacology and applications of Melicope pteleifolia: A review. 61
31926313 2020
369
Increased Mortality in Asians With Systemic Sclerosis in Northern California. 61
32198914 2020
370
The relationship of serum SCUBE-1, -2 and -3 levels with clinical findings and ultrasonographic skin thickness in systemic sclerosis patients. 61
31991528 2020
371
Asthma-chronic obstructive pulmonary disease overlap in China: prevalence, associated factors and comorbidities in middle-aged and older adults. 61
31992091 2020
372
Ultrasonographic evaluation of Achilles tendon: Is there any difference between ankylosing spondylitis, non-radiographic axial spondyloarthropathy and controls? 61
31985181 2020
373
Clinical and Biochemical Phenotypes in a Family With ENPP1 Mutations. 61
31826312 2020
374
Does Leukopenia Influence Performance of the New European League Against Rheumatism/American College of Rheumatology Classification Criteria in an African-Descendent Population With Childhood-Onset Systemic Lupus Erythematosus? Comment on the Article by Aringer et al. 61
31769215 2020
375
Application of the 2019 European League Against Rheumatism/American College of Rheumatology systemic lupus erythematosus classification criteria in clinical practice: a single center experience. 61
32098572 2020
376
[Treatment of systemic sclerosis-associated interstitial lung disease]. 61
31754786 2020
377
Organogold drug Auranofin exhibits anti-melanogenic activity in B16F10 and MNT-1 melanoma cells. 61
31501921 2020
378
[Chloroquine phosphate: therapeutic drug for COVID-19]. 61
32895128 2020
379
Transanal irrigation: is it the magic intervention for bowel management in individuals with bowel dysfunction? 61
32279546 2020
380
Ranunculus bulumei Methanol Extract Exerts Anti-Inflammatory Activity by Targeting Src/Syk in NF-κB Signaling. 61
32260181 2020
381
Toward Defining Primary and Secondary Nonresponse in Rheumatoid Arthritis Patients Treated with Anti-TNF: Results from the BioTRAC and OBRI Registries. 61
31263067 2020
382
Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal? 61
32024651 2020
383
Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study. 61
31654156 2020
384
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM). 61
32094157 2020
385
A rare case of spondyloarthropathy: Iatrogenic hypoparathyroidism. 61
32318681 2020
386
Provision of foot and ankle care services for people with rheumatic and musculoskeletal disease across Europe. 61
31802611 2020
387
[Mucopolysaccharidosis: A review]. 61
31959364 2020
388
[Chikungunya]. 61
32877073 2020
389
First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort. 61
31694813 2020
390
The evaluation of gene polymorphisms associated with autoinflammatory syndrome in patients with palindromic rheumatism complicated by intermittent hydrarthrosis. 61
31897954 2020
391
Response to: 'Ultrasound findings in palindromic rheumatism' by Sanmarti et al. 61
30578295 2020
392
Ultrasound findings in palindromic rheumatism. 61
30552178 2020
393
Chemotaxonomic studies on natural population of Gloriosa superba (L.) collected from Gangetic plain (India) and their invitro antigout activity for the identification of elite germplasm(s). 61
31756449 2020
394
Enthesopathy of the anterior chest wall joints in patients with diffuse idiopathic skeletal hyperostosis (DISH): a retrospective analysis of computed tomography scans. 61
31501958 2020
395
[Supplementary effects of tea in rheumatism and comorbidities]. 61
32146756 2020
396
Prevalence, correlates, and impact of sleep disturbance in Chinese patients with primary Sjögren's syndrome. 61
31763772 2020
397
Attenuation of oxidative stress in arthritic rats by ethanolic extract of Albizia procera benth bark through modulation of the expression of inflammatory cytokines. 61
31785384 2020
398
[RABBIT-SpA: a new disease register for axial spondyloarthritis and psoriatic arthritis]. 61
30874933 2020
399
Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. 61
31927087 2020
400
Hypophosphatemic osteosclerosis, hyperostosis, and enthesopathy associated with novel homozygous mutations of DMP1 encoding dentin matrix protein 1 and SPP1 encoding osteopontin: The first digenic SIBLING protein osteopathy? 61
31843680 2020
401
Clémentine Delait (1865-1934), the most famous bearded lady on the continent in the 20th century. 61
31674848 2020
402
The spectrum of idiopathic inflammatory myopathies in South Africa. 61
32212001 2020
403
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study. 61
31410485 2020
404
Homologies and heterogeneity between Rheumatology Congresses: Mexican, American College of Rheumatology and European League Against Rheumatism. 61
29891264 2020
405
Capillaroscopy in childhood-onset systemic lupus erythematosus: a first systematic review. 61
31858964 2020
406
SLE classification criteria items are not dependent on current activity but may accumulate over time. Response to: 'Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity?' by Teng et al. 61
32122907 2020
407
Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus also indicate the disease activity? 61
32122908 2020
408
The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy. 61
32284726 2020
409
Rapid analysis of Saposhnikovia divaricate decoction metabolism in rats by UHPLC-Q-TOFMS and multivariate statistical analysis. 61
31826299 2020
410
Oral health-related quality of life in primary Sjögren's syndrome. 61
29754950 2020
411
Attenuation of adjuvant-induced arthrits by Stereospermum colais and Stereospermum suaveolens via modulation of inflammatory mediators. 61
31734448 2020
412
Advanced Studies on Rhizoma Dioscoreae Collettii. 61
27286710 2020
413
Peptidylarginine deiminase 4 (PAD4) activity in early rheumatoid arthritis. 61
31544586 2020
414
Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study. 61
31892533 2020
415
DAS28-ESR and DAS28-CRP - are they Interchangeable in Measuring the Activity of Rheumatoid Arthritis in Response to Treatment with Biological Agents? 61
32337896 2020
416
Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis. 61
31853784 2020
417
Adaptation and validation of an Arabic version of a 10-item patient-reported outcome measure of physical function in rheumatoid arthritis. 61
31825149 2020
418
2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease by Wallace et al. 61
32054605 2020
419
Developing classification criteria for skin-predominant dermatomyositis: the Delphi process. 61
31049930 2020
420
Fibroblastic Rheumatism Versus Variant Disease of Multinucleate Cell Angiohistiocytoma. 61
31725486 2020
421
Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome. 61
31578648 2020
422
Worldwide Expert Agreement on Updated Recommendations for the Treatment of Systemic Sclerosis. 61
31043545 2020
423
An association between air pollution and daily most frequently visits of eighteen outpatient diseases in an industrial city. 61
32047168 2020
424
Management of X-linked hypophosphatemia in adults. 61
31863781 2020
425
[Treatment of psoriatic arthritis : Are there differential indications?] 61
31578612 2020
426
Association of HLA-G 3'UTR Polymorphisms with Soluble HLA-G Levels and Disease Activity in Patients with Rheumatoid Arthritis: A Case-Control Study. 61
31549885 2020
427
Enthesitis and its relationship with disease activity, functional status, and quality of life in psoriatic arthritis: a multi-center study. 61
31773391 2020
428
Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS). 61
31662321 2020
429
Myositis-Specific Antibodies and Myositis-Associated Antibodies in Patients With Idiopathic Inflammatory Myopathies From the PANLAR Myositis Study Group. 61
32084069 2020
430
Investigation of the preliminary mechanism of action for the acute anti-inflammatory activity of the methanol extract of Smilax ornata Lem. 61
31676403 2020
431
Sophora alopecuroides L.: An ethnopharmacological, phytochemical, and pharmacological review. 61
31442619 2020
432
Comparison of three sets of clinical classification criteria for knee osteoarthritis: a cross-sectional study of 13,459 patients treated in primary care. 61
31539621 2020
433
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment. 61
31704720 2020
434
Leocarpinolide B attenuates LPS-induced inflammation on RAW264.7 macrophages by mediating NF-κB and Nrf2 pathways. 61
31837308 2020
435
Hydrolysable tannin-rich fraction from Terminalia chebula Retz. fruits ameliorates collagen-induced arthritis in BALB/c mice. 61
31428953 2020
436
Traditional Uses, Bioactive Chemical Constituents, and Pharmacological and Toxicological Activities of Glycyrrhiza glabra L. (Fabaceae). 61
32106571 2020
437
Mentoring for postdoctoral researchers in rheumatology: the Emerging EULAR Network (EMEUNET) post-doc mentoring programme. 61
32584783 2020
438
Singapore Chapter of Rheumatologists updated consensus statement on the eligibility for government subsidization of biologic and targeted-synthetic therapy for the treatment of rheumatoid arthritis. 61
31859424 2020
439
Antiarthritic and Antihyperalgesic Properties of Ethanolic Extract from Gomphrena celosioides Mart. (Amaranthaceae) Aerial Parts. 61
33014104 2020
440
Juvenile Sjögren's Syndrome: Clinical Characteristics With Focus on Salivary Gland Ultrasonography. 61
30697959 2020
441
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. 61
31796497 2020
442
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. 61
31793250 2020
443
Toxicology studies of aqueous-alcohol extracts of Harpagophytum procumbens subsp. procumbens (Burch.) DC.Ex Meisn. (Pedaliaceae) in female and male rats. 61
32020872 2020
444
A good response to glucocorticoid for Henoch-Schönlein purpura with abdominal pain and gastrointestinal bleeding in an adult: A CARE case report. 61
31895810 2020
445
Treatment of periscapular tendinopathy with radiofrequency coblation: A case report. 61
32695397 2020
446
EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases. 61
31229952 2020
447
Epidemiology of musculoskeletal complaints and diseases in Qatar: A cross-sectional study. 61
33282713 2020
448
Exploring protective effect of Glycine tabacina aqueous extract against nephrotic syndrome by network pharmacology and experimental verification. 61
32765640 2020
449
Inflammatory Manifestations of Systemic Diseases in the Central Nervous System. 61
32834714 2020
450
A follow up study of rheumatism (Poncet's Arthritis) among patients with active Tuberculosis. 61
31979698 2020
451
Factors determining response to Hydroxychloroquine therapy in palindromic rheumatism. 61
31979694 2020
452
The Role of Ultrasound Across the Inflammatory Arthritis Continuum: Focus on "At-Risk" Individuals. 61
33195348 2020
453
Acute myocardial injury after administration of intravenous epinephrine for allergic reaction. 61
32595973 2020
454
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. 61
31413005 2020
455
Methodological quality of cohort study on rheumatic diseases in China: A systematic review. 61
32324798 2020
456
Shoulder Ultrasound in the Diagnosis of the Suprascapular Neuropathy in Athletes. 61
32190738 2020
457
CT-Based Evaluation of Diffuse Idiopathic Skeletal Hyperostosis in Adult Population; Prevalence, Associations and Interobserver Agreement. 61
30583921 2020
458
Characteristics of Chinese patients with primary Sjögren's syndrome: preliminary report of a multi-centre registration study. 61
31793380 2020
459
The Prevalence of Calcifications at the Origin of the Extensor Carpi Radialis Brevis Increases with Age. 61
32090141 2020
460
Evaluation of Noxious Consequence of Bark Extract of Onosma echioides Linn Root: Hematology, Biochemistry, and Histopathological Findings. 61
30522376 2020
461
Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits. 61
31353871 2020
462
Therapeutic Aspects of Squill; An Evidence-Based Review. 61
30686259 2020
463
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout. 61
31167758 2020
464
Characterization of the complete chloroplast genome of a well-known Chinese medicinal herb, Scrophularia ningpoensis. 61
33366613 2020
465
Recommendations for the Management of Uveitis Associated With Juvenile Idiopathic Arthritis: The Czech and Slovak adaptation of SHARE Initiative. 61
33086847 2020
466
Applying the 2019 EULAR/ACR lupus criteria to patients from an established cohort: a Latin American perspective. 61
31958284 2020
467
Comparability of European League Against Rheumatology-Recommended Pharmacological Treatments of Oral Ulcers Associated with Behçet's Disease: A Systematic Literature Review of Randomized Controlled Trials. 61
33376418 2020
468
Antioxidant, Anti-Inflammatory, and Analgesic Activities of Aqueous Extract of Diploknema butyracea (Roxb.) H.J. Lam Bark. 61
33354166 2020
469
Dehydrocorydaline Accounts the Majority of Anti-Inflammatory Property of Corydalis Rhizoma in Cultured Macrophage. 61
33299450 2020
470
Psoriatic arthritis epidemiology, comorbid disease profiles and risk factors: results from a claims database analysis. 61
33134811 2020
471
Ultrasound Imaging in Psoriatic Arthritis: What Have We Learnt in the Last Five Years? 61
32984374 2020
472
Innate Cells: The Alternative Source of IL-17 in Axial and Peripheral Spondyloarthritis? 61
33488572 2020
473
Adherence to Subcutaneous Anti-TNF Treatment in Chronic Inflammatory Rheumatism and Therapeutic Patient Education. 61
32158200 2020
474
Diagnosis and Treatment of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors. 61
32832568 2020
475
Application of classification criteria of Sjogren syndrome in patients with sicca symptoms: Real-world experience at a medical center. 61
31303456 2020
476
C1-C2 instability in psoriatic arthritis. 61
32963683 2020
477
Metabolic Pattern of Systemic Sclerosis: Association of Changes in Plasma Concentrations of Amino Acid-Related Compounds With Disease Presentation. 61
33195431 2020
478
Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study. 61
33093777 2020
479
Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis: Two case reports. 61
31977898 2020
480
2018 Update of the EULAR recommendations for the management of large vessel vasculitis. 61
31270110 2020
481
Isolation of Oxyberberine and β-Sitosterol from Berberis lycium Royle Root Bark Extract and In Vitro Cytotoxicity against Liver and Lung Cancer Cell Lines. 61
32617102 2020
482
Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography in Inflammatory Rheumatism, Particularly Polymyalgia Rheumatica: A Retrospective Study of 222 PET/CT. 61
32923444 2020
483
Higher rate of rheumatic manifestations and delay in diagnosis in Brazilian Fabry disease patients. 61
31907047 2020
484
Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis. 61
33354232 2020
485
Assessment of enthesis in patients with psoriatic arthritis and fibromyalgia using clinical examination and ultrasound. 61
32116207 2020
486
Interaction of the microbiota with the human body in health and diseases. 61
32328397 2020
487
Psoriasis and systemic lupus erythematosus in children - literature review based on case report. 61
32322124 2020
488
Subclinical atherosclerosis and endothelial dysfunction in patients with polymyalgia rheumatica: a pilot study. 61
31418315 2020
489
Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. 61
32023206 2020
490
Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention. 61
31880245 2020
491
Association between Dental Treatment, Quality of Life, and Activity Limitation According to Masticatory Discomfort: Evidence from the Korean National Health and Nutrition Examination Survey (2013-2015). 61
31952176 2020
492
Sigesbeckia glabrescens Makino extract attenuated the collagen-induced arthritis through inhibiting the synovial hyperplasia and inflammation. 61
32874196 2020
493
Antioxidant Phytoconstituents From Onosma bracteata Wall. (Boraginaceae) Ameliorate the CCl4 Induced Hepatic Damage: In Vivo Study in Male Wistar Rats. 61
32973525 2020
494
Aconitine induces cardiomyocyte damage by mitigating BNIP3-dependent mitophagy and the TNFα-NLRP3 signalling axis. 61
31657084 2020
495
Behcet's disease involved the root of aorta in the treatment with modified Bentall procedure: a case report. 61
31996248 2020
496
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies. 61
31672775 2020
497
Chemical composition and evaluation of the antinociceptive, antioxidant and antimicrobial effects of essential oil from Hymenaea cangaceira (Pinto, Mansano & Azevedo) native to Brazil: A natural medicine. 61
31580941 2020
498
Impact of lower limb osteoarthritis on health-related quality of life: A cross-sectional study to estimate the expressed loss of utility in the Spanish population. 61
31978194 2020
499
A Qualitative Study of Patients' Beliefs and Perception on Medicinal Properties of Natural Hot Spring Bath for Musculoskeletal Problems. 61
32695190 2020
500
In Vitro Antioxidant Activities of the Aqueous and Methanolic Stem Bark Extracts of Piliostigma thonningii (Schum.). 61
32664742 2020
501
Chemical Constituents and Pharmacological Activities of Family Flacourtiaceae: A Class of Important Phytomedicine. 61
32160758 2020
502
[To the 125th birthday of Professor Vyacheslav Konstantinovich Beletsky]. 61
32593270 2020
503
Mitochondrial Function and Root-Filled Teeth - Detrimental and Unknown Interfaces in Systemic Immune Diseases. 61
32765044 2020
504
Analgesic Mechanism of Sinomenine against Chronic Pain. 61
32454918 2020
505
2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. 61
31300458 2020
506
A Comprehensive Review of the Genus Pyrola Herbs in Traditional Uses, Phytochemistry and Pharmacological Activities. 61
31797760 2020
507
N-Butanol Extract of Gastrodia elata Suppresses Inflammatory Responses in Lipopolysaccharide-Stimulated Macrophages and Complete Freund's Adjuvant- (CFA-) Induced Arthritis Rats via Inhibition of MAPK Signaling Pathway. 61
32063980 2020
508
Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis. 61
33519474 2020
509
Glucocorticoids in rheumatoid arthritis: current status and future studies. 61
31958273 2020
510
Chinese Herbal Formula Huayu-Qiangshen-Tongbi Decoction Compared With Leflunomide in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis: An Open-Label, Randomized, Controlled, Pilot Study. 61
33015085 2020
511
JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data. 61
32982367 2020
512
Diagnostic value of the serum Midkine in patients with rheumatoid arthritis. 61
31324694 2020
513
Clinical and Structural Efficacy of Hydroxychloroquine in Rheumatoid Arthritis: A Systematic Review. 61
30629341 2020
514
Assessing Associations of Synovial Perfusion, Cartilage Quality, and Outcome in Rheumatoid Arthritis Using Dynamic Contrast-enhanced Magnetic Resonance Imaging. 61
30877219 2020
515
Is prediction of clinical response to methotrexate in individual rheumatoid arthritis patients possible? A systematic literature review. 61
30981868 2020
516
Predictive values of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in relation to serological aspects of the ACR/EULAR 2010 classification criteria for rheumatoid arthritis. 61
31264518 2020
517
Subjective sleep disturbances at the time of diagnosis in patients with polymyalgia rheumatica and in patients with seronegative elderly-onset rheumatoid arthritis. A pilot study. 61
32921825 2020
518
Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors-data from a large national quality register. 61
31969172 2020
519
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis. 61
32346301 2020
520
Association of 17 Definitions of Remission with Functional Status in a Large Clinical Practice Cohort of Patients with Rheumatoid Arthritis. 61
31043552 2020
521
"There is something you must see": breaking down the remission concept in rheumatoid arthritis from a rheumatologist's perspective. 61
31573477 2020
522
Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC). 61
31582377 2019
523
[Epidemiology and outcome of patients with rheumatic diseases in the intensive care unit]. 61
31468166 2019
524
Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies. 61
31875667 2019
525
Ant schnapps for health and pleasure: the use of Formica rufa L. (Hymenoptera: Formicidae) to flavour aquavit. 61
31856874 2019
526
[Damage to periarticular soft tissues in real clinical practice: frequency, nature, effectiveness of non - steroidal anti - inflammatory drugs]. 61
32598585 2019
527
Regulation of P-glycoprotein by Bajijiasu in vitro and in vivo by activating the Nrf2-mediated signalling pathway. 61
30929555 2019
528
A case study of vertebral fusion in a 19th-century horse from Serbia. 61
31550619 2019
529
Trends in Prescription Analgesic Use Among Adults With Musculoskeletal Conditions in the United States, 1999-2016. 61
31825504 2019
530
Ethnopharmacology of the club moss subfamily Huperzioideae (Lycopodiaceae, Lycopodiophyta): A phylogenetic and chemosystematic perspective. 61
31376517 2019
531
[CURRENT TRENDS IN THE PREVENTION, DIAGNOSIS AND TREATMENT OF RHEUMATIC FEVER AND RHEUMATIC HEART DISEASE (REVIEW)]. 61
32011302 2019
532
[Controlling glucocorticoid treatment in critically ill patients with rheumatism exemplified by systemic lupus erythematosus]. 61
31410548 2019
533
Limited role of specificity of ANA for SLE classification. Response to: 'European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist's point of view' by Infantino et al. 61
31831507 2019
534
ANA as an entry criterion for the classification of SLE. 61
31639513 2019
535
Rare Finding of Bilateral Pseudoangiomatous Stromal Hyperplasia of the Breast: A Case Report. 61
31768994 2019
536
[Clinical characteristics analysis of 1 808 rheumatism in-patients with oral candidiasis]. 61
31874483 2019
537
Synthesis and characterization of gold nanoparticles from Marsdenia tenacissima and its anticancer activity of liver cancer HepG2 cells. 61
31328556 2019
538
Long-term trends in rheumatology care : Achievements and deficits in 25 years of the German national rheumatology database. 61
31407089 2019
539
Is TNF inhibitor exposure a risk factor for amyotrophic lateral sclerosis? 61
31058354 2019
540
Atypical case of diffuse idiopathic skeletal hyperostosis mimicking ankylosing spondylitis in a young woman with polycystic ovary syndrome. 61
31929491 2019
541
Comparison of sexual function in Tunisian women with rheumatoid arthritis and healthy controls. 61
31392560 2019
542
EULAR/ACR classification criteria for SLE. 61
31779843 2019
543
Valuing health using EQ-5D: The impact of chronic diseases on the stock of health. 61
31502362 2019
544
Elucidation of the possible mechanism of analgesic action of methanol stem bark extract of Uapaca togoensis pax in mice. 61
31415847 2019
545
Imaging in Large Vessel Vasculitides. 61
31096287 2019
546
Cervical proprioceptive impairment in patients with rheumatoid arthritis. 61
31435752 2019
547
[A systemic disease mimicking a rheumatoid arthritis]. 61
31444022 2019
548
Clinical effectiveness and safety of additional administration of tacrolimus in rheumatoid arthritis patients with an inadequate response to abatacept: A retrospective cohort study. 61
31647174 2019
549
Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort. 61
31872182 2019
550
Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis. 61
32010889 2019
551
Coix lachryma-jobi extract ameliorates inflammation and oxidative stress in a complete Freund's adjuvant-induced rheumatoid arthritis model. 61
31747811 2019
552
[Rheumatism and bone metabolism]. 61
31531702 2019
553
[Rheumatism and the mind-A mini review]. 61
31559467 2019
554
Effects of Eugenia umbelliflora O. Berg (Myrtaceae)-leaf extract on inflammation and hypersensitivity. 61
31377260 2019
555
Characterization of the complete chloroplast genome of Paederia scandens (Rubiaceae): a Chinese folk medicinal plant. 61
33366325 2019
556
Interactions of drug-metabolizing enzymes with the Chinese herb Psoraleae Fructus. 61
31831132 2019
557
[Three years of the appointment service office: high rate of false referrals and no show patients-A retrospective anaysis of the Rheumatism Center Schleswig-Holstein Mitte]. 61
31197458 2019
558
[Physical activity, exercise and nutrition in rheumatism : Adjuvant treatment options for inflammatory-rheumatic diseases]. 61
31562547 2019
559
[Rheumatism and gastroenterology]. 61
31686154 2019
560
Prevalence of pain and associated factors in Brazilian civil servants: an introductory analysis using baseline data from the ELSA-Brasil cohort. 61
31984301 2019
561
[Clinical analysis of FRAX in the assessment of fracture risk in patients with rheumatic disease in three medical center]. 61
31715673 2019
562
Swollen joints and peripheral arthritis are signs of malignancy in polymyalgia rheumatica. 61
30334628 2019
563
Coix lacryma-jobi var. ma-yuen Stapf sprout extract induces cell cycle arrest and apoptosis in human cervical carcinoma cells. 61
31729992 2019
564
The Use of Transthoracic Echocardiogram to Quantify Pulmonary Vascular Resistance in Patients with Systemic Sclerosis. 61
30824639 2019
565
Less severe disease in patients with early systemic sclerosis? 61
30472907 2019
566
[The skin and rheumatism]. 61
31535157 2019
567
Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern". 61
31520797 2019
568
Effectiveness of Statins as Primary Prevention in People With Gout: A Population-Based Cohort Study. 61
31248268 2019
569
The burden of health conditions across race and ethnicity for aging Americans: Disability-adjusted life years. 61
31725658 2019
570
Chamaejasmine Isolated from Wikstroemia dolichantha Diels Suppresses 2,4-Dinitrofluoro-benzene-Induced Atopic Dermatitis in SKH-1 Hairless Mice. 61
31694198 2019
571
[Higher prevalence of depressive and anxiety symptoms in early arthritis patients in comparison to the normal population]. 61
30511171 2019
572
Posttraumatic C5 Palsy After Application of Hard Collar in Ankylosing Spondylitis. 61
31356975 2019
573
Preliminary Report on Interleukin-22, GM-CSF, and IL-17F in the Pathogenesis of Acute Anterior Uveitis. 61
31763950 2019
574
Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study. 61
31783773 2019
575
European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist's point of view. 61
31757781 2019
576
X-linked hypophosphatemia: Management and treatment prospects. 61
30711691 2019
577
Prosopis Plant Chemical Composition and Pharmacological Attributes: Targeting Clinical Studies from Preclinical Evidence. 61
31775378 2019
578
Rapid Analysis of the Chemical Compositions in Semiliquidambar cathayensis Roots by Ultra High-Performance Liquid Chromatography and Quadrupole Time-of-Flight Tandem Mass Spectrometry. 61
31766221 2019
579
Synovial-Fluid miRNA Signature for Diagnosis of Juvenile Idiopathic Arthritis. 61
31779271 2019
580
To what extent is multi-morbidity associated with new onset depression in patients attending cardiac rehabilitation? 61
31726981 2019
581
Systematic analysis of the metabolites of Angelol B by UPLC-Q-TOF-MS after oral administration to rats. 61
31831129 2019
582
Cellular proliferation/cytotoxicity and antimicrobial potentials of green synthesized silver nanoparticles (AgNPs) using Juniperus procera. 61
31762645 2019
583
Palindromic rheumatism as part of the rheumatoid arthritis continuum. 61
31595059 2019
584
Abatacept retention and clinical outcomes in rheumatoid arthritis: real-world data from the German cohort of the ACTION study and a comparison with other participating countries. 61
31300979 2019
585
Evidence of Diagnostic and Treatment Delay in Seronegative Rheumatoid Arthritis: Missing the Window of Opportunity. 61
31619364 2019
586
Recent Advances in Kaempferia Phytochemistry and Biological Activity: A Comprehensive Review. 61
31591364 2019
587
[Rheumatological care in the Rheumazentrum Ruhrgebiet Rheumatism Center-a model for conurbations]. 61
31286192 2019
588
Practical management of patients on Janus kinase inhibitor (JAKi) therapy: Practical fact sheets drawn up by the Rheumatism and Inflammation Club (CRI), a group endorsed by the French Society for Rheumatology (SFR). 61
31791545 2019
589
Outcome in juvenile idiopathic arthritis: a population-based study from Sweden. 61
31661011 2019
590
Ultrasound and clinical features of hip involvement in patients with gout. 61
30779966 2019
591
[The interpretation of 2018 updated European League Against Rheumatism evidence based recommendations for the diagnosis of gout]. 61
31594172 2019
592
Lychnophora pinaster ethanolic extract and its chemical constituents ameliorate hyperuricemia and related inflammation. 61
31252094 2019
593
Comparative Efficacy and Safety of Nonsurgical Treatment Options for Enthesopathy of the Extensor Carpi Radialis Brevis: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials. 61
30380334 2019
594
Lung Ultrasound as a Screening Method for Interstitial Lung Disease in Patients With Systemic Sclerosis. 61
30028804 2019
595
Diffuse idiopathic skeletal hyperostosis in a 33-year-old woman with PCOS and metabolic syndrome: a rare scenario. 61
31676500 2019
596
[Long-term trends in rheumatology care : Achievements and deficits in 25 years of the German national rheumatology database]. 61
31297603 2019
597
Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study. 61
31625875 2019
598
[Endogenous Endophthalmitis: Epidemiology, Clinic, Therapy and Visual Outcome]. 61
29642263 2019
599
The Brazilian Society of Rheumatology recommendations on investigation and diagnosis of systemic autoimmune myopathies. 61
31601261 2019
600
Amelioration of hepatic function, oxidative stress, and histopathologic damages by Cassia fistula L. fraction in thioacetamide-induced liver toxicity. 61
31407268 2019
601
Bioactivity-guided isolation of flavonoids from Urtica dioica L. and their effect on endometriosis rat model. 61
31325603 2019
602
[Research progress on chemical constituents and bioactivities of Lepidium meyenii]. 61
31872691 2019
603
The clinical and radiographic course of early knee and hip osteoarthritis over 10 years in CHECK (Cohort Hip and Cohort Knee). 61
31202721 2019
604
Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire. 61
31217169 2019
605
Impact of Patient's Global Assessment on Achieving Remission in Patients With Rheumatoid Arthritis: A Multinational Study Using the METEOR Database. 61
30821895 2019
606
Recurrent Thrombosis With Direct Oral Anticoagulants in Antiphospholipid Syndrome: A Systematic Literature Review and Meta-analysis. 61
31405527 2019
607
Efficacy of rituximab in resistant palindromic rheumatism: first report in literature. 61
31076945 2019
608
Applying EMG technology in medial and lateral elbow enthesopathy treatment using Myo motion controller. 61
31201609 2019
609
Traditional uses, secondary metabolites, and pharmacology of Celastrus species - a review. 61
31129308 2019
610
Ethnobotanical uses, biological activities and chemical properties of Kei-apple [Dovyalis caffra (Hook.f. & Harv.) Sim]: An indigenous fruit tree of southern Africa. 61
31132461 2019
611
Ethnic Variations in Systemic Sclerosis Disease Manifestations, Internal Organ Involvement, and Mortality. 61
30824634 2019
612
Rituximab in systemic sclerosis: A protocol for systematic review. 61
31567948 2019
613
Phytochemical constituents and ethnopharmacological properties of Ageratum conyzoides L. 61
31290201 2019
614
The 100 top-cited publications in psoriatic arthritis: a bibliometric analysis. 61
30315571 2019
615
External Validation and Evaluation of Adding MRI or Extended Myositis Antibody Panel to the 2017 EULAR/ACR Myositis Classification Criteria. 61
31777826 2019
616
Study of vertebral fracture and Scanographic Bone Attenuation Coefficient in rheumatoid arthritis and ankylosing spondylitis vs. controls. 61
31527613 2019
617
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. 61
31385462 2019
618
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. 61
31383717 2019
619
Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry. 61
31491989 2019
620
Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice. 61
31090930 2019
621
[Research advancement in mechanisms of processing and compatibility for detoxication of Aconitums]. 61
31602941 2019
622
Determinants of diagnosis and disease course in primary Sjögren's syndrome: Results from datamining of electronic health records. 61
31328441 2019
623
Phenolic compounds from the stems of Fissistigma polyanthoides and their anti-oxidant activities. 61
31271787 2019
624
Effects of Achyranthes bidentata alcohol on proliferation capacity of osteoblasts and miRNA in Runx2. 61
31410108 2019
625
Devil's claw (Harpagophytum procumbens) and chronic inflammatory diseases: A concise overview on preclinical and clinical data. 61
31273865 2019
626
Impact of sleep quality on clinical features of primary Sjögren's syndrome. 61
29458245 2019
627
Long-Term Physical Activity and Subsequent Risk for Rheumatoid Arthritis Among Women: A Prospective Cohort Study. 61
30920773 2019
628
[Depressive symptoms in early rheumatoid arthritis : Within the rheumatism network ADAPTHERA]. 61
31016369 2019
629
Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity score matching analysis. 61
31102087 2019
630
Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance. 61
30092161 2019
631
Quality of Life in Ecuadorian Patients With Rheumatoid Arthritis: A Cross-sectional Study. 61
29102587 2019
632
Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts. 61
31561582 2019
633
Effectiveness of subcutaneously administered methotrexate in patients with rheumatoid arthritis. 61
31464109 2019
634
Monotherapy is a relevant option in rheumatoid arthritis treatment: a literature review. 61
31376250 2019
635
Expression of a PYCARD/ASC variant lacking exon 2 in Japanese patients with palindromic rheumatism increases interleukin-1β secretion. 61
31421660 2019
636
Evaluation of antiamnesic activity of Salvia multicaulis essential oil on scopolamine-induced amnesia in rats: in vivo and in silico approaches. 61
31440590 2019
637
Severe odontogenic infections with septic progress - a constant and increasing challenge: a retrospective analysis. 61
31375095 2019
638
Fangchinoline, a Bisbenzylisoquinoline Alkaloid can Modulate Cytokine-Impelled Apoptosis via the Dual Regulation of NF-κB and AP-1 Pathways. 61
31466313 2019
639
Association of Maternal Neurodevelopmental Risk Alleles With Early-Life Exposures. 61
31042271 2019
640
The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report. 61
31464894 2019
641
[Overview of hepatotoxicity studies on Tripterygium wilfordii in recent 20 years]. 61
31602901 2019
642
Fumaric acids as a novel antagonist of TLR-4 pathway mitigates arsenic-exposed inflammation in human monocyte-derived dendritic cells. 61
31397191 2019
643
Consensus-based recommendations for the management of juvenile localised scleroderma. 61
30826775 2019
644
Efficient Extraction of Anti-Inflammatory Active Ingredients from Schefflera octophylla Leaves Using Ionic Liquid-Based Ultrasonic-Assisted Extraction Coupled with HPLC. 61
31416166 2019
645
Rheumatoid Arthritis Treatment. A Back to the Drawing Board Project or High Expectations for Low Unmet Needs? 61
31426398 2019
646
Baseline adenosine receptor mRNA expression in blood as predictor of response to methotrexate therapy in patients with rheumatoid arthritis. 61
31203399 2019
647
DPP-4 inhibitor (sitagliptin)-induced seronegative rheumatoid arthritis. 61
31444259 2019
648
A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients. 61
30647443 2019
649
Ultrasound as a Useful Tool in the Diagnosis of Rheumatoid Arthritis in Patients With Undifferentiated Arthritis. 61
30946286 2019
650
Usefulness of 18 F-Labeled Fluorodeoxyglucose-Positron Emission Tomography for the Diagnosis of Lymphoma in Primary Sjögren's Syndrome. 61
30615273 2019
651
Reproducibility of Ocular Surface Staining in the Assessment of Sjögren Syndrome-Related Keratoconjunctivitis Sicca: Implications on Disease Classification. 61
31453437 2019
652
Three-dimensional ultrashort echo time (3D UTE) MRI of Achilles tendon at 4.7T MRI with comparison to conventional sequences in an experimental murine model of spondyloarthropathy. 61
30575218 2019
653
Clinical correlates of HLA-B*27 and its subtypes in enthesitis-related arthritis variant of juvenile idiopathic arthritis in south Indian Tamil patients. 61
30884197 2019
654
Factors associated with health care seeking behavior for musculoskeletal pain in Indonesia: A cross-sectional study. 61
30828984 2019
655
Pitfalls in diagnosing geriatric general pain: coexistence of polymyalgia rheumatism and fibromyalgia. 61
31340948 2019
656
[Loss of quality of sleep and associated factors among menopausal women]. 61
31340284 2019
657
Arthritis prevention in the pre-clinical phase of RA with abatacept (the APIPPRA study): a multi-centre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol. 61
31307535 2019
658
Capillaroscopy changes are associated with disease progression in patients with early systemic sclerosis: A prospective study. 61
31050209 2019
659
The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey. 61
31259293 2019
660
Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria. 61
30554156 2019
661
Validation of 2017 classification criteria for adult and juvenile idiopathic inflammatory myopathies proposed by EULAR/ACR in Chinese patients. 61
31124267 2019
662
Which one? What kind? How many? Types, causes, and prevalence of disability among U.S. adults. 61
31000498 2019
663
Ultrasound detected changes in joint cartilage thickness in juvenile idiopathic arthritis. 61
31117159 2019
664
Veronica Plants-Drifting from Farm to Traditional Healing, Food Application, and Phytopharmacology. 61
31277407 2019
665
Serum drug concentrations to optimize switching from adalimumab to etanercept in rheumatoid arthritis. 61
31012365 2019
666
Influence of disease duration and socioeconomic factors on the prevalence of infection and hospitalization in rheumatoid arthritis: KRAC study. 61
30977300 2019
667
Impact and Timing of Smoking Cessation on Reducing Risk of Rheumatoid Arthritis Among Women in the Nurses' Health Studies. 61
30790475 2019
668
Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis. 61
29334721 2019
669
The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis. 61
31277720 2019
670
Relapsing periodic arthritis, palindromic rheumatism and MEFV gene-related variants alleles in children. 61
31171010 2019
671
The effect of anti-IL-6 receptor antibody for the treatment of McH-lpr/lpr-RA1 mice that spontaneously developed destructive arthritis and enthesitis. 61
31200688 2019
672
Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease. 61
30204909 2019
673
The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values. 61
31155722 2019
674
Study on the diagnosis of gout with xanthine and hypoxanthine. 61
30803031 2019
675
Performance of the 2015 American College of Rheumatology/European League against Rheumatism Classification Criteria for Gout in Korean Patients with Acute Arthritis. 61
31172694 2019
676
Symphytum Species: A Comprehensive Review on Chemical Composition, Food Applications and Phytopharmacology. 61
31216776 2019
677
[Treat to target-participation of the patient]. 61
30937529 2019
678
Calotropis gigantea extract induces apoptosis through extrinsic/intrinsic pathways and reactive oxygen species generation in A549 and NCI-H1299 non-small cell lung cancer cells. 61
31215445 2019
679
Drimia indica: A Plant Used in Traditional Medicine and Its Potential for Clinical Uses. 61
31181697 2019
680
Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross-Sectional Study. 61
30552835 2019
681
Novel paradigms in systemic lupus erythematosus. 61
31180031 2019
682
Risk of juvenile idiopathic arthritis among children conceived after fertility treatment: a nationwide registry-based cohort study. 61
30927428 2019
683
The Turkish Society of Physical Medicine and Rehabilitation (TSPMR) guideline recommendations for the management of fibromyalgia syndrome. 61
31453551 2019
684
Osthole induced apoptosis in human normal liver cells by regulating cell proliferation and endoplasmic reticulum stress. 61
30848542 2019
685
Maytenus macrocarpa (Ruiz & Pav.) Briq.: Phytochemistry and Pharmacological Activity. 61
31226757 2019
686
Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients. 61
31242943 2019
687
Antinociceptive and anti-arthritic effects of aqueous whole plant extract of Trianthema portulacastrum in rodents: Possible mechanisms of action. 61
30930256 2019
688
Nagarines A and B, two novel 8,15-seco diterpenoid alkaloids from Aconitum nagarum. 61
30914332 2019
689
Glycine tabacina ethanol extract ameliorates collagen-induced arthritis in rats via inhibiting pro-inflammatory cytokines and oxidation. 61
30880257 2019
690
[Medical assistant-a profession in a state of flux]. 61
30874931 2019
691
New lignans from Urticae Fissae Herba. 61
29623730 2019
692
Ribes orientale: A novel therapeutic approach targeting rheumatoid arthritis with reference to pro-inflammatory cytokines, inflammatory enzymes and anti-inflammatory cytokines. 61
30872172 2019
693
Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study. 61
31130260 2019
694
Comparison of Adults With Polyarticular Juvenile Idiopathic Arthritis to Adults With Rheumatoid Arthritis: A Cross-sectional Analysis of Clinical Features and Medication Use. 61
29781829 2019
695
High Proportion of Subjective Component to the Disease Activity Score is Associated with Favorable Response to Abatacept in Rheumatoid Arthritis. 61
30484084 2019
696
Cardiovascular Disease Risk in Older Adults and Elderly Patients with Rheumatoid Arthritis: What Role Can Disease-Modifying Antirheumatic Drugs Play in Cardiovascular Risk Reduction? 61
30953327 2019
697
Pro-apoptotic and anti-inflammatory effects of araloside A on human rheumatoid arthritis fibroblast-like synoviocytes. 61
31004595 2019
698
Patient Perspectives on the Value of Patient Preference Information in Regulatory Decision Making: A Qualitative Study in Swedish Patients with Rheumatoid Arthritis. 61
30443897 2019
699
Should nasal biopsy inevitably be performed for classifying granulomatosis with polyangiitis in patients with rhinosinusitis? A retrospective chart review study. 61
30887162 2019
700
Development and Formative Evaluation of a Communication Skills Training Program for Persons with Rheumatic and Musculoskeletal Diseases. 61
29388797 2019
701
#EULAR2018: The Annual European Congress of Rheumatology-a Twitter hashtag analysis. 61
30778654 2019